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Introduction and aim 
Tobacco farmers are exposed to toxic workplace hazards such as nicotine and 
pesticides in addition to known agriculture related hazards like dust, and ergonomic 
factors. Nicotine and pesticide exposure have been linked to the development of chronic 
respiratory diseases. This study was aimed at determining the prevalence of obstructive 




A cross-sectional study was conducted comprising of 279 current workers across four 
flue-cured tobacco farms in rural Zomba district of Malawi during a tobacco growing 
season. The assessment involved the use of a modified ECRHS questionnaire and 
questions on pesticides and nicotine exposure. Voluntary HIV testing was offered to 
individuals who did not know their HIV status. Health outcomes assessment involved 
the use of both symptom and spirometry-based diagnoses of obstructive lung disease. 
The data was analyzed using STATA 14 computer software and included bivariate and 
multivariate logistic regression analysis. 
 
Results  
The study had predominantly male participants (68%) with a total mean age of 37.7 
years, majority (73%) of whom had attained primary education or higher, with 20% 
being current smokers.  Participants had a mean employment duration of 7.3 years and 
62% indicated that they worked mainly with tobacco while 57% were involved in 
pesticides application. HIV prevalence was 16%. The prevalence of current asthma 
(ECRHS) was 20% whilst for asthma score≥2 it was 23%. The prevalence of chronic 
bronchitis, work related ocular nasal symptoms and work- related chest symptoms were 
17%, 20% and 29%, respectively. Airflow Limitation measured as FEV1 <80% was 
found to be 20% and 31% for FEV1<LLN (NHANES and sample reference); and that of 
FEV1/FVC <70% was 8% and FEV 1< LLN was 14% (NHANES and sample reference). 
The prevalence of moderate to severe obstruction was 4%.  
 vi 
 
The prevalence of green tobacco sickness (a proxy for nicotine exposure) in the past 
year was 26% with an average of 3 episodes within that period. Most workers were 
exposed to pesticides with 72% reporting exposure during spraying of pesticides while 
83% reported re-entry into fields soon after spraying. The main pesticide in use was 
organophosphates (18%). The majority (51%) of participants reported use of 
organophosphate pesticides at home.  
 
In multivariate analysis nicotine exposure and associated tasks were significantly 
associated with all respiratory outcomes (OR range 1.78-7.26). Pesticide application 
was positively associated with all the symptom-based respiratory outcomes (OR 1.96-
2.62) except for work related chest symptoms. Exposure during spraying was 
significantly associated with asthma score≥2 (OR 2.09, CI 1.01-4.31), current asthma 
(OR 2.57, CI 1.22-5.40), and work related ocular nasal symptoms (OR 2.43, CI 1.17-
5.04) while pesticide drift was associated with current asthma (OR 2.62, CI 1.00-6.86) 
and work related ocular nasal symptoms (OR 3.00, CI 1.18-7.62). In spirometry-based 
outcomes duration of pesticide exposure was significantly associated with 
FEV1/FVC<LLN (OR 5.11, CI 1.57-16.66), FEV1/FVC<70% (OR 4.58, CI 1.17-17.98) 
and moderate to severe obstruction (OR 13.25, CI 1.69-103.93). Nicotine exposure was 
not significantly associated with spirometry-based outcomes. 
 
Conclusion  
In conclusion, this study showed that tobacco farmers in Malawi have a higher 
prevalence of asthma and chronic bronchitis compared to the general population or 
tobacco farmers in other settings. Additionally, exposure to nicotine and pesticides is 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
1.1 INTRODUCTION AND BACKGROUND 
Malawi has a population of about 17 million people. Most of the economically active are 
employed in the informal sector where 89% of the labor force is absorbed. Malawi’s 
economy is known to heavily depend on agriculture for both subsistence and commercial 
reasons.  Tobacco is  the main cash crop 1 and Malawi is ranked among the five largest 
tobacco producers globally 2, relying on it as a major source of foreign revenue and 
involving about 20% of the national labor force. Tobacco cultivation in Malawi involves a 
considerable proportion of the labor force in all regions across the country. Farmers 
cultivate either as households or tenants as well as through employment in large estates. 
Most estates in the southern part of Malawi employ perennial casual labor on their estates.  
 
The process of cultivating tobacco involves the use of chemicals, frequent contact with the 
tobacco leaves, and other exposures related to field preparation and tobacco processing 
such as curing. Given the magnitude of the population subjected to tobacco farm 
exposures in Malawi it is of paramount importance to understand the burden of tobacco 
related health effects in this particular population. 
 
Studies have demonstrated that tobacco farm exposures are  associated with diverse 
health effects including Green Tobacco Sickness (GTS) due to  nicotine exposure, 
pesticide poisoning and respiratory disease as a result of skin and inhalational exposure3. 
A study by Plan International among Malawian tobacco farms focused on child labor 
revealed occurrence of green tobacco sickness in children but did not report on respiratory 
effects4. There is no documented study in this population to our knowledge that focused on 
the respiratory effects associated with tobacco cultivation. Several studies have been 
documented in Malawi concerning respiratory diseases in the general population but the 
majority have dwelled on infectious diseases5. Other studies that have investigated 
obstructive lung diseases are available but have not demonstrated the impact of workplace 
environment in such conditions5,6.
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Globally there is limited information about the role of tobacco farming in obstructive lung 
diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. The 
context in Malawi provides an opportunity to study and understand the relationship 
between tobacco farming exposures and prevalence of obstructive lung disease. 
 
1.2 LITERATURE REVIEW  
1.2.1 Literature search strategy 
 
This review focusses on chronic respiratory diseases associated with tobacco cultivation 
with special attention to asthma and COPD. To identify relevant articles, a search was 
conducted on MEDLINE and Google scholar on respiratory health effects associated with 
tobacco farming within a period from 1970-2016 using different combinations of the 
following key words “tobacco farming” “respiratory health effects” “COPD” “asthma” 
“allergy” “nicotine farm exposure” “pesticides health effects” “organophosphates health 
effects” “HIV in farmers”. These articles were further surveyed for additional citations, 
which were incorporated in the review if relevant. The review focused on characterizing 
tobacco farming and its associated exposures, exploring the common health effects 
reported by tobacco farmers and specifically focusing on articles dealing with chronic lung 
disease prevalent in this population. An evaluation of risk factors and potential 
confounders associated with obstructive lung disease in this population was also 
undertaken. 
 
1.2.2 The tobacco cultivation process  
Tobacco cultivation has shifted from high income countries (HICs) to low- and middle- 
income countries (LMICs)  following  campaigns against its cultivation in developed 
countries7. The negative health impacts of this shift are accentuated in the LMICs due to 
the lack of occupational health regulation, poverty as well as poor access to healthcare8. 
Among the top world tobacco producers are countries such as the United States of 
America, China, Brazil, India, and Malawi 1. Malawi is unique in that it is heavily dependent 
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on the crop for its economy as well as being the lowest income country listed among the 
significant tobacco producers. Due to the economic status of Malawi there is insufficient 
infrastructure to support such large- scale tobacco production and the use of modern 
farming technology is limited. This results in excessive manual work with indigenous and 
rudimentary methods of cultivation being employed in tobacco-farming. The larger quantity 
of tobacco produced in Malawi employs the use of sharecroppers1,3 . These are contract 
farmers given land to farm. Sharecroppers are supplied with farm inputs with an 
agreement to share the produce with the land owners. This practice has been associated 
with the labour force being drawn from households in efforts to increase the share of small-
scale farmers. According to the Food and Agriculture Organization (FAO), households’ 
involvement in tobacco farming have been associated with a number of issues such as 
more people per household being exposed to adverse health effects and the use of child 
labour. 
 
Malawi produces three main types of tobacco: Burley which forms about 82% (can reach 
89%) of total mass production, followed by flue cured which constitutes about 17%, and 
dark-fired tobacco 9. Burley is a light air cured variety that is mainly used for cigarette 
production and mainly produced by small holder famers who own their own small farms or 
as sharecroppers. The flue cured variety is produced by high earning large scale 
production estates which use casual and seasonal laborers for cultivation. Flue cured 
tobacco is dried in a closed building with furnace driven heat directed from flues that 
extend from the furnace into the barn. The dark-fired variety is dried by using wood smoke 
from small fires built on the floors of enclosed curing barns which gives it a characteristic 
flavor for chewing, snuff and pipe tobacco mixtures.  
 
In Malawi, the tobacco season commences around July with preparation of nurseries and 
preparing beds for seeding. This involves tilling and hoeing mainly using hand held tools. 
After bed preparations, the beds are sterilized using chemicals or burning the top soil using 
dried biomass. Sowing follows this, and soon after sowing there is a judicious application 
of chemicals (pesticides and herbicides) in the nurseries to control different types of pests 
and weeds until transplantation time, which occurs after about 12 weeks. Following 
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transplantation, the plants mainly grow by seasonal rains. During this phase, weeding as 
well as pest control occurs. Later, budding is controlled either chemically, or mechanically 
by removing them off the plant to improve leaf quality. This process occurs while the plant 
is at an advanced height and is associated with high exposure to nicotine from the buds 
and leaves especially when personal protective equipment is not worn. An outline of the 




Figure 1.1: The typical tobacco cultivation process (with permission 8) 
 
Pesticides in the Malawian context are applied by the sharecroppers as part of the whole 
cultivation process. As a monocrop, tobacco plants are vulnerable to a variety of pests and 
diseases, which require the application of large quantities of chemicals.10 These include 
pesticides (insecticides, herbicides, fungicides and fumigants) and growth regulators 
(growth inhibitors and ripening agents), which are applied to the tobacco plants during 
different stages of growth.10 In LMICs, pesticide and growth inhibitors are usually applied 
with hand held or backpack sprayers, without the use of the necessary protective 
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equipment.10 In Malawi the most widely used pesticides are neonicotinoids, 
organophosphates, and carbamates according to the Tobacco Control Commission. Some 
weeks after topping, harvesting occurs. Depending on the variety of tobacco, harvesting 
may occur in several rounds or once off. When it occurs once off tobacco is harvested by 
cutting the whole plant and taking off the leaves for stacking, later. In contrast, when 
harvesting in rounds only matured leaves are harvested, leaving behind the rest of the 
plant for the next round of harvest.  
 
After harvesting the leaves are stacked into barns for drying in case of air drying for barley, 
or they are taken into curing barns for flue-cured or dark-fired varieties of tobacco. Except 
for air curing the other types of curing require the use of firewood smoke to give it a 
characteristic flavor. After drying the leaves are packed into bales for trading at an auction. 
Since the responsibility of cultivation is handled by households, although under the control 
of the Tobacco Commission of Malawi, the use of personal protection is suboptimal. Most 
of the farmers do not use protective equipment for protection against various hazards as 
these are perceived as additional costs of production and may be unaffordable. Some 
large estates that use casual labor as opposed to sharecroppers are responsible for 
providing personal protective equipment, however, there are no clear guidelines or 
regulation for safe handling of chemicals and tobacco plants made available to the 
employees. 
 
1.2.3 Common occupational and environmental exposures associated with tobacco 
farming 
 
Tobacco cultivation is associated with exposure to various hazards as a result of working 
in dusty environments, inhaling smoke when curing the tobacco, using chemicals such as 
pesticides during cultivation and nicotine from skin contact while harvesting the tobacco 
leaves (Table 1.1). The use of casual laborers in large estates exposes a very large group 
of employees to particular hazards. While it is expected that these estates should have 
capacity to supply and enforce PPE use among their  employees, observation shows that 
this is not the case and it is not uncommon for these seasonal workers to forget some 
safety practices regarding their work in relation to prevailing hazards. 




Table 1.1: Exposures associated with tobacco cultivation tasks 
TASK ACTIVITIES INVOLVED POSSIBLE HAZARDS 
Tilling Use of hoes to break the soil to 
prepare beds 
Organic and inorganic dust  




Rubble and straw are burnt on top of 
the prepared beds 




Use of sprayers and watering canes 
to mix, spray, then clean the 
equipment 
Dermal, respiratory exposure 
to Pesticides  
and dermal exposure to 
Nicotine  
Ergonomic 
Topping Removal of the budding appendages Dermal exposure to Nicotine  
Pesticides  
Ergonomic 
Harvesting Removal of the whole plant or 
leaves depending on the tobacco 
variety 
Dermal exposure to Nicotine  
Ergonomic 
Stacking  Systematically attaching and 
suspending the leaves for drying 
Dermal exposure to Nicotine  
Ergonomic  
Curing  Use of some form of fuels (e.g. 
wood) to generate heat for drying 
tobacco 
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1.2.3.1 Dose response relationships between exposures and their effects 
 
Dust, nicotine and pesticides mediate their health effects in a dose dependent manner. 
Although nicotine effects tend to wane off with continued exposure due to tolerance, 
pesticides and dust effects worsen with continued and intensity of exposure 11.  
 
Not much is known about the interaction of nicotine and pesticides at the 
pathophysiological level. A Thai study aimed at identifying correlation of health effects of 
nicotine and pesticides exposure, found that certain symptoms of GTS such as nausea 
and vomiting occurred at safe exposure levels to organophosphates,  while headache and 
increased salivation were associated with higher exposure levels 12. Wheezing was 
associated with having GTS in the previous year and those with more than 5 episodes in 
the previous year had twice the risk of developing wheezes according to a Brazilian 
study13. The limitation of this study is that no quantitative exposure measures were taken; 
either for nicotine or pesticides and it is difficult to determine whether this relationship had 
to do with retention of high nicotine levels in the body during the current year. 
 
Several studies have demonstrated dose dependent health effects related to dust 
exposure among tobacco factory workers. Workers with a higher cumulative dust exposure 
had significantly lower lung indices against their predicted values compared to 
controls14,15,16.  
 
Since tobacco cultivation involves concurrent exposure to dust as well as other chemicals 
such as pesticides and nicotine there is a need to evaluate their long-term respiratory 
effects among farmers.  
 
1.2.3.1.1 Particulate tobacco Dust 
 
Dust is defined as solid particles made airborne by the mechanical disintegration of bulk 
solid material or biological particles and usually consists of particles in sizes ranging from 
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1-100µm although ultrafine particles (UFPs) are usually less than 0.1µm. It is classified as 
inhalable, thoracic and respirable dust based on particle size. Inhalable dust (10 -100.0μm) 
is the fraction of total airborne particles that are inhaled through the nose and/or mouth. 
Thoracic dust (4-10μm) is that which can penetrate the respiratory system beyond the 
larynx. Respirable dust (4μm and below) is the fraction of airborne particles that can reach 
the alveoli where gas exchange occurs17. 
A Chinese study on tobacco dust exposure characterized the tobacco dust in a tobacco 
processing factory15. The average dust concentration ranged from 12.78 to 23.85mg/m3. 
This was beyond the recommended average of vegetable dusts of 3mg/m3. While most of 
the dust was organic the tobacco carried along other inorganic dust from the farms such as 
silica reaching close to 11% of the total dust content in tobacco. In this particular study 
between 80-97% of the measured particles were respirable dust.  
 
Unlike the tobacco processing factory environment, cultivation is associated with exposure 
to both organic and inorganic dusts to a greater extent. The source of organic dust is the 
plant matter such as the dried tobacco leaves which is common in the barns and shades 
13. During field work workers are mainly exposed to inorganic dust from field soils which 
are usually composed of silica. A study in  Zimbabwe among tobacco farmers reported 
levels of respirable tobacco dust of 19.13 ± 10.82 mg/m3, which was much higher than the 
occupational exposure limit for inhalable dust8. 
 
There are no conventional occupational exposure limits for most dust encountered in 
tobacco farming. What is clear is that exposure to a mixture of organic and inorganic dusts 
makes it a complex exposure to quantify and assess. In China tobacco dust is grouped 
among vegetable dust and given an exposure limit of 3mg/m3 for the processing 
factories15. Studies on tobacco farms of particulate dust levels report levels between  2-
20mg/m3 with some studies reporting levels as high as 100mg/m3 among open cabin farm 
tractor drivers 1819.  Several studies aimed at quantifying respirable dust levels using 
personal sampling among harvesters, showed concentrations of 0.52 to 2.16mg/m3 while 
levels outside tractors were between 1.77 to 5.24 mg/m3 during field preparation19. A 
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study among seasonal and permanent tobacco factory workers in Greece investigated 
suspended dust levels in a tobacco factory using static samples and showed 
concentrations of magnitude as high as 45.3 to 54.4 mg/m3 20. This shows how dust is 
prevalent both in the tobacco fields as well as tobacco processing settings thereby posing 
some risk to workers in those environments. 
Several factors have been demonstrated to be associated with changing dust particulate 
exposures in the field, which include differences in equipment, tasks, and climate. In one 
study, the presence of an enclosed tractor cabin, higher relative humidity, and lower tractor 
speed were both associated with lower dust exposure levels19. 
1.2.3.1.2 Nicotine 
Nicotine is a water soluble odorless chemical and one of the chemicals produced by the 
tobacco plant. It has stimulatory effects on the central nervous and autonomic system 
through special nicotinic receptors 21. It has tolerant and addictive effects on those 
exposed to it and its effects may not be appreciated even in higher doses in those 
chronically exposed to it. Nicotine can enter the body through dermal, oral, or by inhalation 
exposures. It is metabolized by the liver and excreted by the kidneys. Unlike the oral route, 
dermal and inhalation routes of exposures allow nicotine to reach the brain, lungs, and 
other organs without the first pass effect 21,22.  
Most farmers are exposed to nicotine through dermal exposure involving contact with 
tobacco plants in the field during budding or harvesting. This  poses a particular risk of 
high circulatory levels of nicotine especially during wet conditions 2. Factors associated 
with high nicotine exposure include wet conditions, type of tobacco (Burley or Virginia 
tobacco have a high nicotine content and burley is predominant in Malawi), and alcohol 
consumption during work in tobacco cultivation and /or processing. Work practices such as 
longer work shifts, topping, and harvesting 2,3,7 all predispose to excessive nicotine 
exposure. 
Nicotine is metabolized faster than most of its metabolites such as cotinine. Seventy 
percent of nicotine is extracted from the blood with each pass through the liver at a 
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clearance rate of 1200ml per min compared to cotinine at 45ml per min. Because of its 
short half-life most studies have used metabolites such as cotinine for biological monitoring 
of nicotine exposure. Non-smoking status is generally associated with having a serum 
cotinine of less than 10ng/ml 23. One study found cotinine levels of more than 10ng/ml 
among exposed tobacco workers 7. Observed levels of cotinine above 50ng/ml/m2 were 
associated with additional eye symptoms in exposed tobacco farmers 24.  
A toxicological test on a patient with green tobacco sickness in Poland found cotinine 
levels as high as 869ng/ml 25. One review demonstrated high cotinine levels in non-
smoking tobacco  farmers that were as high and comparable to smokers 2. Not many 
toxicological studies have been published on quantitative analysis of nicotine exposure 
among tobacco farmers. Studies among tobacco farmers have instead focused on the use 
of symptomatology of nicotine related conditions such as green tobacco sickness to 
characterize its toxicity. This approach, however, has the potential to miss out exposure 
data among asymptomatic or tolerant individuals who might be harmed despite not 
manifesting with green tobacco sickness.  
1.2.3.1.3 Pesticides 
Pesticides are chemicals used to control diseases and parasites including weeds in 
agricultural production. Tobacco farming involves the utilization of a large amount of 
diverse pesticides. The application of these chemicals occurs at the beginning of the 
season and tapers down at different stages until harvesting which potentially results in 
continued chemical exposure to farmers. The common chemicals used in this regard are 
summarized in the Table 1.2 below. 
The commonly used chemicals are organophosphates, pyrethroids, synthetic pyrethroids, 
and neonicotinoids, among others26. A study among Pakistani tobacco farmers reported a 
high concentration of neonicotinoid, carbamate, pyrethroid and organochlorine pesticide 
residues above the acceptable daily intake (ADI) for humans in the blood of tobacco 
farmers8. Health effects among pesticide handlers are associated with the type of 
pesticide, number of chemicals handled, use of protective equipment, duration of 
exposure/tasks, age, and gender.  
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Pesticide exposure occurs mainly through dermal, inhalation, and ingestion routes  27,28. 
This allows the chemicals to reach the lungs without a first pass effect thereby exerting 
their possible effects before they are eliminated or altered. Most organophosphates are 
applied within two weeks after transplantation of seedlings is done. From transplantation to 
harvesting it takes about eight weeks. Most exposure to organophosphates occur during 
application which involves mixing, spraying, and cleaning of the instruments 29. Although 
sprayers are the ones most at risk, any other farm workers in contact with the crop some 
days after spraying may also be exposed.  
Different techniques have been used to monitor workers’ exposure levels to 
organophosphates to address the issue of individual variations in dose response 
relationship. For organophosphates, a 50% reduction in Cholinesterase (ChE) from the 
baseline is associated with acute cholinergic or toxic symptoms and the recommended 
removal threshold for workers from exposure is a reduction of 60% for red cell ChE and 
50% for plasma ChE. Workers may return to work if their ChE levels reach 75% of the 
baseline level 27,29. However, chronic health effects related to organophosphates have 
been observed in individuals without necessarily showing significant difference of ChE 
levels compared to baseline 27.    
 
Farmers are usually exposed to more than a single type of pesticide per growing season 
and the interaction between these combined effects are not well understood. Older age 










   12
 
 
Table 1.2: Pesticides used commonly in Malawi tobacco industry and reported associated 
respiratory effects among farming populations 
Name of Group Active Chemical Associated Respiratory 
effect (Reference) 
Neonicotinoids  Imidacloprid 
 Acetamiprid 
 Thiamethoxam 
Respiratory irritation   
Reduced lung volumes 
(29) 








Organophosphates   Dimethoate 
 Chloropyriphos 
 
Rhinitis, wheeze, reduced 




Herbicides   Trifulalin 
 S Metolachlor 
 





1.2.4 Health effects associated with tobacco cultivation 
 1.2.4.1 Green Tobacco Sickness 
Acute nicotine exposure in tobacco farmers has been associated with a condition called 
Green Tobacco Sickness (GTS). It occurs within hours of heavy exposure to nicotine and 
is usually self-limiting with spontaneous recovery in the next 48 hours 21. It was first 
described in the 1970’s as a neurotoxic syndrome characterized by headache, nausea, 
vomiting and headache. Other symptoms may also be present such as abdominal cramps, 
diarrhea and palpitations. It occurs as a result of stimulation of cholinergic receptors in the 
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nervous system 3,21. This is the most commonly documented specific health effect among 
tobacco farmers having a seasonal prevalence of up to 89% 2. Incidence of GTS was 
shown to increase with time during the tobacco season 31. It is more prevalent among  
young workers who are new to the occupation and those that come in contact with green 
tobacco leaves such as harvesters and chemical sprayers especially under wet conditions 
32,33.   
 
Hygiene measures such as hand washing and use of personal protective equipment, 
especially gloves, were associated with significant reduction in GTS in two separate 
studies  34,35. Two interventional studies found a significant reduction (62-75%) of risk of 
GTS when rubber gloves were used compared with cotton gloves 35.  
 
In a Brazilian study assessing prevalence of wheezing, a history of  GTS  was observed to 
be a risk factor for wheezing among tobacco farmers13. However, due to a tolerance effect 
of nicotine on exposed individuals, the presence of the green tobacco sickness alone is a 
poor indicator of high levels of nicotine exposure in a population that is chronically exposed 
to nicotine. 
 
1.2.4.2 Respiratory health effects 
 
Tobacco handling has been associated with different kinds of occupational respiratory 
problems such as upper and lower respiratory symptoms; compromised lung function 
indices; including specific conditions like asthma, rhinitis, and COPD3 as seen in Table 4 
below. Most available data are based on factory workers, who work in dusty environments 
exposed to organic dusts. In addition, exposure to some inorganic dusts in the context of 
tobacco cultivation predisposes farmers to the health effects associated with inorganic dust 
exposure which include COPD. 
 
A study among workers in a cigarette factory in Italy observed an association between 
duration of exposure to tobacco dust and symptoms such as cough, phlegm, wheezing 
among both smokers and nonsmokers14. 
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The study among tobacco processing workers in a Chinese plant revealed a decline in 
percentage of the predicted pulmonary function compared to controls15. Other studies 
have demonstrated higher percentages (14.3%) of mean diurnal variation in peak 
expiratory flow among tobacco workers compared to controls (9.8%)36. In this study 
tobacco workers had significantly lower FVC and FEV1 values compared to controls. 
 
1.2.4.2.1 Asthma and Rhinitis 
Pesticides  
Studies on pesticide handlers show an increased risk for rhinitis and asthma among this 
group of workers. Both allergic and non-allergic wheezes have been associated with 
pesticide application 3,37,38. Though these studies were not all on tobacco farmers 
themselves they reveal a potential link that may exist in tobacco farming given the 
exposure to pesticides in the process of tobacco cultivation. 
  
Tobacco pesticides such as organophosphates, pyrethroids, neonicotinoids, and 
herbicides have been associated with several respiratory effects. These range from acute 
symptoms to chronic conditions some of which have been demonstrated in lung function 
tests. As shown in the table 2  the most common effects are wheezes, rhinitis, as well as 
atopic and nonatopic asthma39,40,41,42.  
 
There is consistent evidence that growing up in farms in general is protective for atopic 
asthma and rhinitis compared to the general population 43–45. It has further been suggested 
from those studies that such protection is due to exposure to endotoxins in atopic airway 
disease.  
 
A review by Ngajilo et al shows the prevalence of rhinitis-like symptoms (nasal congestion, 
runny nose and itchiness around eyes and nose) among tobacco farmers to be between 
8% and 34%8. Factors such as harvesting and topping were shown to be associated with 
runny, stuffy nose in one study. A review 46 focusing on occupational pesticide exposure 
and respiratory health  showed that asthma and chronic bronchitis were associated with 
pesticide exposure either as an applicator or farmer. Repeated exposure to pesticides was 
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also shown to be associated with increased prevalence of wheeze, which suggests a link 
between pesticide exposure and airway disease. 
 
Dust role  
Studies have shown the role of dust in both upper and lower respiratory symptoms. 
Ignacak et al. found that chronic or recurrent nasal symptoms were more common among 
employees exposed to tobacco dust as compared to the control group (40% versus l3.3%, 
p = 0,018). The exposed population had loss of cilia and squamous epithelial metaplasia 
compared to controls. However, their tobacco specific IgE did not differ compared to 
controls and they did not demonstrate hyper-eosinophilia. This suggested that the 
symptoms were due to irritant effects as opposed to allergic mechanisms.47 Another 
Brazilian study evaluating wheezes in tobacco farmers found an association between dust 
exposure and wheeze13.  
 
The development of both atopic and irritant induced asthma/rhinitis have been associated 
with farming 48. Organic dust exposure from tobacco leaves was associated with wheezing 
supporting evidence from other studies linking asthma to organic dusts13. A case report of 
a patient with features suggestive of occupational asthma due to dried tobacco leaves 
exposure has also been reported8. In this case, sensitization to tobacco leaf was confirmed 
by a positive skin-prick test (SPT) using an extract of dried Paraguay Bell leaf. A specific 
bronchial-challenge test using the same tobacco, not contaminated by mold, was 
associated with a 23% fall in FEV1. This suggested an IgE dependent sensitisation to 
tobacco leaf as one of the mechanisms for occupational asthma in tobacco farm workers8. 
Although not many studies have been documented regarding asthma and rhinitis among 
tobacco workers one can infer a potential for increased risk described in the studies above.  
 
Nicotine role 
A Brazilian study on the prevalence of wheezing among tobacco farmers found a greater 
risk of wheezing associated with lifting sticks with tobacco leaves to be hung in barns, 
monthly frequency of pesticides use, dry tobacco leaf dust and GTS compared to other 
tasks of low exposure 13. From such findings, it can be appreciated that tasks that are 
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likely to increase nicotine exposure are among the risk factors for wheeze in this 
population.  
 
In the factory setting, a study that assessed both upper and lower airway disease in 
tobacco factory workers found an increased association between upper airway diseases 
and dust exposure while the data did not support any association of tobacco dust with 
lower airway disease 20. There is need for more quantitative epidemiological evidence of 
the association with asthma among tobacco farmers since this was the only published 
study in this setting.  
 
There remains a gap in knowledge on the potential effects of chronic nicotine exposure in 
agricultural settings on inflammatory response of airways of tobacco farmers. 
 
1.2.4.2.2 COPD and Interstitial lung disease 
Pesticides role 
An agricultural health study showed that exposure to organophosphates, pyrethroids and 
other pesticides increased the risk of chronic bronchitis in farmers with Odds Ratios (OR) 
ranging from 1.41-1.70 depending on the type of pesticides or herbicides used 49. Although 
these pesticides do not primarily act on the respiratory system, toxicological studies have 
revealed adverse health outcomes on the respiratory system related to their use.  
 
Acute exposure effect episodes are very good predictors of  occurrence of chronic 
effects.50  However, it is not uncommon to observe chronic health effects related to 
pesticides use among farmers in the absence of preceding acute effects.  
 
Dust role  
There is emerging evidence that exposure to silica as well as vapors, gases, dusts, fumes 
(VGDF) is responsible for a growing global burden of COPD according to research data 
over the past two decades51,52,53. A review by Blanc and others on the relationship of 
COPD and occupation showed a population attributable fraction of at least 15% of COPD 
to VGDF. The greater components of these VGDF are classified as low toxicity dusts and, 
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therefore, receive little or no attention in terms of occupational exposure monitoring 54. The 
process of tobacco cultivation and processing involves exposure to different forms of 
VGDF from land preparation to curing, sorting, packaging and selling. Despite this 
exposure, there is little information on the health effects of VGDF and other associated 
chemicals on tobacco farmers.  
 
The majority of studies on respiratory diseases of tobacco workers have been conducted 
in tobacco processing settings where the workers mostly encounter dried tobacco dust. In 
one study, tobacco plant workers involved in processing tobacco and exposed to dried 
tobacco dust had an increased risk of developing COPD compared to controls 38. Similarly, 
a study conducted in a farm setting using lung function tests of tobacco farm workers 
exposed to dust,  revealed evidence of COPD 55.Tobacco farm workers are exposed  to 
tobacco dust including nicotine and pesticides which could alter the magnitude of COPD 
burden in that population. In a similar setting a Zimbabwean study among flue-cured 
tobacco workers showed an increase in COPD cases when compared to vegetable 
farmers 56.  
 
 
Nicotine role  
In vitro, nicotine has been shown to affect the mucin formation in the airways as well as 
disrupting the surfactant levels in the lungs 57. It has been postulated through these 
mechanisms that nicotine may increase airway resistance and predispose to obstructive 
pulmonary disease. One study showed that nicotine exposure through tobacco smoke 
favors proliferation of rat airway smooth muscle cells and could explain its role in 
obstructive pulmonary disease 58. Since these studies are mainly laboratory-based trials 
on animals, it is difficult to determine the exposure levels in the occupational setting that 
are likely to mimic such effects. Nicotine in tobacco farming is associated with dermal 
absorption and whilst systemic effects are possible, the mechanism for pulmonary effects 
are not well understood.   
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Despite these findings there is limited evidence available for the association of tobacco 
farming exposures and the prevalence of COPD among tobacco farmers. 
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Literature review Occupational allergy 
and asthma in tobacco 
farmers 
Not applicable Not applicable Tobacco farming was associated with 
Rhinitis, asthma, allergic alveolitis, 
spirometric abnormalities 
 
Fiori N et al 
2015 
 Cross-sectional 
study of 2469 
tobacco farmers  
In Brazil 
Predictors of wheezing 
in Tobacco Farm 
workers 
Contact with green 
tobacco, dried 
tobacco, pesticides, 
GTS among others 
Wheezing  General prevalence of wheezing of 11%. 
Among men wheezing associated with 
pesticides use, green tobacco, dried 
tobacco, strenuous work, age, GTS, 
smoking. 
Among women wheezing was 
associated with contact with tobacco, 
contact with pesticides, family history of 
asthma, GTS, strenuous work.  
Siavash E et al 
2009 
Cohort study of 





Pulmonary function in 
workers exposed to 





lung capacities and 
air flow 
 
Marked reduction in PEF (78% vs 105%, 
p<0.001), FEF25% (76% vs 102%, 
p<0.001), and PIF (75% vs 98%, 
p<0.001) among the exposed group 
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Increased abnormalities for both FEV1 and 
FVC among the exposed group compared to 
controls (p<0.01 or <0.05) 
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and 469 controls 
In Greece 
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Tobacco workers had a lower prevalence 
(8.7% vs 20.6%) of bronchitis and higher 
rhinitis (27.3% vs 17.9%) in workers 
compared to controls 
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Respiratory findings in 








6.2% asthma in tobacco workers vs 0 in 
controls and workers had a lower FEV1 
compared to controls 
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tests (FVC, FEV1, 
PEF) 
Tobacco workers had significantly lower FVC and 
FEV1 compared to controls.  
Tobacco workers had a higher diurnal variation in 
PEF than controls. 
Viegi G et al 
1986 
Cross-sectional 
study of 89 men, 
93 young women, 
and 40 older 
women categorized 
based on smoking 





















Chest X-ray findings 
Among men, in the order of NS<6, NS>6, S<6, 
and S>6, chronic cough (4%, 12%, 14%, and 25% 
respectively; chi square = 4-28, p < 0 05), chronic 
phlegm (9%, 12%, 10%, and 25%; chi square = 4-
17, p < 0 05), and wheezing (0%, 12%, 29%, and 
32%; chi square = 9-84, p < 0-01). 
Pulmonary function tests showed a decreasing 
but nonsignificant trend with employment duration 
and smoking 
 




















tests (FVC, FEV1) 
X-ray findings 
Significant reduction in FEV1 was noted among 
the exposed smokers and nonsmokers 





1.2.5 Risk factors associated with obstructive lung disease in tobacco workers 
Several factors have been associated with development of respiratory conditions 
among tobacco farmers. Major factors include host factors such as atopy, gender, 
comorbidities such as HIV or TB; occupational factors such as job tasks, and 
environmental factors such as biomass fuel. 
1.2.5.1 Host factors 
1.2.5.1.1 Atopy 
A Norwegian study showed that crop farming is associated with a higher prevalence of 
atopic asthma compared to animal farming 59. In a Brazilian study assessing the 
prevalence of wheezing among tobacco farmers, a  family history of asthma was  found 
to be associated with wheezing although existence of atopy was not measured 
objectively 13. Generally, there are very few documented studies on atopic factors in 
crop farm workers, specifically tobacco farmers. 
 
1.2.5.1.2 Sex 
A study in Vietnam showed that female farm workers were more likely to have tobacco 
related symptoms than male counterparts37. Although adult onset asthma has been 
shown to be more common in females, in the Brazilian study of wheezing among 
tobacco farmers the gender stratified prevalence was the same. It is worth noting, 
however, that males in this study had more exposures related to asthma risks such as 
smoking compared to females 13.  
 
1.2.5.1.3 Age 
With regard to pesticide use, age was shown to be associated with more severe 
symptoms among farmers 60. However, effects of nicotine appear to present with worst 
symptoms among the  population of young farmers 61. The latter finding, is not 
consistently demonstrated in many studies as directly related to age per se but rather to 
years of experience in tobacco cultivation. 
 
1.2.5.1.4 HIV -Status 
Although HIV is endemic in most African countries that cultivate tobacco, the burden of 
HIV among tobacco farmers is not known. It is a well-established fact that HIV 




altered immune responses and  toxic metabolic processes related to anti-retroviral 
therapy 62–64. As stated earlier TB which predisposes to the development of COPD is 
strongly associated with HIV infection. According to WHO, HIV positive individuals are 
between 26 and 31 times more likely to develop TB infection compared to those without 
HIV65-66. Some studies among HIV infected smokers show that nicotine exposure  is 
associated with increased viral replication, suppressed cell mediated immunity, 
increased risk of asthma and allergy, and increased risk of COPD 64. These studies 
were done on smokers rather than individuals occupationally exposed to nicotine. 
These studies demonstrated that nicotine was able to do this through its action on 
nicotinic receptors on immune cells and through the action of its metabolic 
intermediates on CYP2A6 67. It is not clear whether higher nicotine exposures 
encountered during tobacco cultivation could have a similar impact on the health of 
tobacco farmers and whether such an effect may be modified by HIV status. 
 
1.2.5.1.5 Smoking status 
Smoking is a major risk factor for asthma and COPD. A study on COPD conducted 
among adults in urban Malawi revealed a 10.4% prevalence of ever-smoked individuals 
while other studies have reported a lower population prevalence of 4% 6. Among 
Brazilian tobacco farmers the smoking prevalence was dominated by males at 30%  
compared to females at 3%, and in males this was associated with occurrence of 
wheeze13,68,69.  
 
1.2.5.2 Occupational factors 
 
1.2.5.2.1 Job tasks 
The Brazilian study on tobacco farmers showed an increased risk of wheezing in men 
involved with strenuous work and lifting sticks with tobacco leaves to the curing barns13.  
Among the females in that study, strenuous work and tying hands of tobacco were 
associated with wheezing. 
 
1.2.5.3 Environmental factors 
1.2.5.3.1 Biomass Fuel use 
Occupational biomass fuel exposure in tobacco cultivation occurs through the fire 




Tobacco curing carries high risk of exposure to tobacco dust, ammonium, nicotine, 
carbon monoxide, carbon dioxide, furanic aldehyde, moulds and fungi. The curing 
process which usually occurs in airtight barns at a constant temperature level (for 72–
96 hours), may take up to eight weeks. This requires farmers to constantly enter curing 
barns to add leaves and branches to an open fire. During this period, farmers inhale 
large quantities of smoke, which increases their risk of acquiring respiratory disease8.  
 
There  is  widespread biomass fuel use (about 90%) in the sub-Saharan African context 
especially in the rural areas for non-occupational purposes such as everyday cooking 
70. In an urban-based Malawian study, 85.2% of the participants were exposed to 
biomass fuel through domestic use of firewood, charcoal, or paraffin lamps 6. Reliance 
on firewood was associated with significantly higher odds of respiratory and 
constitutional symptoms such as shortness of breath, difficulty breathing, chest pains, 
night phlegm, forgetfulness, dizziness, and dry irritated eyes in rural Malawi71. Biomass 
fuel use was associated with ever wheeze in a study done in Nepal72. A review by 
Guoping Hu and others showed an association between biomass fuel use and COPD 
development in all sexes and Asian as well as non-Asian populations73. Since tobacco 
growing communities are usually remote from the cities, their use of biomass fuel is 
likely to be higher than the general population.  
 
1.2.6 Conclusion  
Available evidence suggests that tobacco famers encounter significant work-related 
hazardous exposures during the cultivation process, among which are nicotine, 
pesticides, and particulate dusts. Additionally, tobacco smoke, tuberculosis, and 
biomass fuel exposure are being increasingly recognized as important risk factors for 
chronic lung disease in developing countries74. While all these exposures have been 
linked to the development of chronic respiratory disease, the effect of concomitant 
exposures to these agents in a setting of high HIV prevalence  needs to be evaluated. 
Knowledge generated from such a study is needed to inform intervention programs 
aimed at controlling all these factors to minimize the occurrence of chronic respiratory 




CHAPTER 2: AIMS, OBJECTIVE AND METHODS 
 
2.1 JUSTIFICATION AND PURPOSE 
Although a body of literature exists that deals with acute health effects of nicotine and 
pesticides among tobacco farmers, there remains a huge gap in knowledge about their 
chronic effects. Moreover, very few studies have attempted to study the associations of 
such exposures with respiratory disease occurrence. Among those that have studied 
respiratory health effects, most have lacked objective measurement tools in their 
assessment of exposures and outcomes. This study focusses on the association 
between respiratory health and tobacco farming among Malawian farmers with 
concomitant exposure to nicotine in tobacco leaves and pesticides.  
 
This study adopts a more objective approach to quantifying the prevalence of COPD 
and asthma among tobacco farmers and determining the role of nicotine and pesticide 
exposure in the occurrence of these conditions. This will be carried out in the context of 
identifying and controlling for potential confounders implicated in the development of 
these conditions. In this particular setting, factors to be considered are the roles of HIV 
status, biomass fuel use, smoking, and previous tuberculosis episode. Although the 
majority of farmers cultivate burley tobacco, there are several occupational health and 
social protection implications associated with flue cured tobacco by the nature of the 
employment in such large estates as well as the magnitude of workplace exposures 
associated with their specific working conditions. 
 
This is the first study, to our knowledge, that attempts to evaluate the effect of 
concurrent exposure to nicotine and pesticides on the prevalence of respiratory disease 
in the context of a HIV prevalence  among flue cured tobacco farmers in Malawi. 
 
The findings of this study would help to inform recommendations on the control of risk 
factors associated with development of obstructive lung disease among tobacco 







Concurrent exposure to nicotine and pesticides during tobacco cultivation increases the 
risk of developing obstructive lung disease among flue cured tobacco farmers.  
 
2.3 RESEARCH QUESTIONS 
1. What are the respiratory health effects of individuals with concurrent exposure to 
nicotine and pesticides among tobacco farmers in Malawi? 
2. What is the prevalence of obstructive lung disease and  lung function impairment in 
Malawian tobacco farmers? 
3. How does HIV infection, biomass fuel combustion exposures, pulmonary tuberculosis 




To determine the association between concurrent exposure to nicotine and pesticides 
with measures of obstructive lung disease among flue cured tobacco farmers in Zomba 
district of Malawi. 
 
2.5 OBJECTIVES  
1. To determine the prevalence of obstructive lung disease (asthma and COPD) among a 
population of tobacco farmers in Malawi   
2. To describe the exposure to nicotine and pesticides in this population using self- 
reported indices of exposure  
3. To evaluate the role of nicotine and pesticide exposure as well as additional factors 
associated with potentially increased risk for obstructive lung disease in this population 
such as gender, smoking status, HIV status, previous tuberculosis episode, exposure to 
biomass fuel. 
 





2.6.1 Study design 
This was a cross sectional study targeting all the estate farmer worker population of 
>18 years of age working on four estate farms in Malawi between December, 2017 and 
January 2018. This study was conducted during spraying and topping season which 
also includes some weeding. 
2.6.2 Study population 
Zomba district is located in the southern part of Malawi where there are at least 15 
large flue cured tobacco estates75 and some small holder farmers which, together 
constituted a population of 5000 tobacco workers. The workers studied in this district 
were estate employees of four large tobacco estates. Flue cured tobacco farmers were 
considered an appropriate population that would allow measurement of all the 
exposures considered in this study due to the very nature of the cultivation process. 
Zomba provided a convenient source of flue cured tobacco estates. 
 
2.6.3 Sampling strategy 
Participants were  selected from the largest estates of the district based on the 
Tobacco Control Commission employment statistics. The four neighbouring largest 
estates that include flue curing as part of the tobacco process were chosen. These 
employ between 80 (on the smallest farm) and 350 (on the largest farm) seasonal 
workers each year. All available farm workers during a shift aged 18 years and above 
within these tobacco estates were invited to participate. Invitations were made to all 
departments in order to have representation from all departments.  
 
2.6.4 Sample size  
A Brazilian study among tobacco farmers reported a prevalence of 3 to 28% for 
asthma-like symptoms138. Other local studies in Malawi on a non-farming community 
reported a 10% prevalence for an obstructive lung function.  The sample size therefore 
assumed a prevalence of obstructive lung disease (COPD and asthma) in this 
population to be 10%76. Further consideration for computing sample size is the 
population size of about 5,000 in the Zomba district and using a 95% confidence level. 
Using an online sample size calculator77,78 the sample size needed for determining the 





2.6.5 Data collection 
 
Health outcome assessment 
 
i) Questionnaire 
Each participant answered a modified European Community Respiratory Health Survey 
II questionnaire (Appendix 1). The questionnaire was modified for local conditions and 
was also translated into Chichewa and back translated to assess validity and 
reproducibility. The questionnaire was administered by trained interviewers. The 
questionnaire was designed to be completed within 30-40 minutes and had various 
components. The questionnaire included participant’s demographic characteristics such 
as age, gender, seniority, smoking habits and occupational information. Standardized 
questions were asked about respiratory symptoms and history of respiratory disease.  
This included asthma and COPD- related symptoms such as wheeze, tight chest, 
cough and shortness of breath and rhino conjunctivitis symptoms such as sneezing, 
itchy eyes and blocked nose. The questionnaire was supplemented with questions 
relating to the history of a participant’s asthma (medication used, asthma attacks, 
doctor visits).  Occupational information focused on the job history, workplace setting, 
job tasks and duration and frequency of exposure to nicotine and pesticide. Questions 
on other potential risk factors for the development of obstructive lung disease such as: 




All interviewed workers were subjected to spirometry at the end of their shifts and all 
American Thoracic Society (ATS)/ERS guidelines for conducting spirometry were 
followed79. The EasyOn PC Spirometer was used. It utilizes digital ultrasonic flow 
measurement technology, which ensures accurate results, repeatable performance and 
quality control. Trained nurses conducted spirometry of 10 individuals on average per 
day. Spirometry was performed in a sitting position without a nose clip. Each worker 
performed up to eight trials to produce three acceptable curves. Test reproducibility 
was used as a guide to whether further attempts will be necessary. Reproducibility 
criteria was the two best tracings for both FEV1 and FVC varying by no more than 150 




not result in exclusion of the spirogram results from the statistical analysis. Poor 
reproducibility may also be an independent marker of airway dysfunction. 
Technologist/testers were trained to ensure the quality of spirograms.  
 
The lung function indices of primary interest included forced vital capacity (FVC) and 
forced expiratory volume in one second (FEV1). The best FEV1 and FVC were used 
regardless of whether they belonged to the same tracing. Lung volumes obtained by 
spirometry were adjusted for body temperature and pressure according to the 
temperature and atmospheric pressure measured on a continuous basis throughout the 
day. Reference values of the National Health and Nutrition Examination Survey III were 
used for spirometry interpretation, with lower limits corresponding to the 95th percentile. 
Heights and weights of workers were recorded for calculating predicted lung function 
indices using National health and Nutrition Examination Survey III (NHANES III) 
equations. Workers were provided with special instructions to ensure that tested 
individuals do not smoke tobacco (at least 2 hours before) and do not take any anti-
asthmatic inhalers (12 hours before) or oral asthma medications (48 hours before) prior 
to the test. The results of lung function tests were recorded on a lung function tests 
data collection sheet (Appendix 6). 
 
iii) HIV Status 
HIV status was determined by first self-reporting and verification by requesting consent 
to check the health passport documentation. Where the participant has not had any 
previous provider- initiated test, such counselling and testing was offered using HIV 
rapid test kits with outcomes stated as positive or negative or unknown (categorical 
variable). Participants who tested positive were appropriately referred for further care 




Qualitative health risk assessment per farm 
A brief walk-through survey with the estate supervisor/manager was done to evaluate 
and familiarize the researcher with the occupational setting. Aspects that were  
assessed included : farm size, prevalent hazards related to tobacco cultivation and  




of exposure, etc on each farm.  Questions related to tobacco handling practices 
(sowing, transplanting, pest control, harvesting, curing and stacking) were included to 
arrive at a qualitative understanding of exposure and different phases involved in 
tobacco farming. 
 
2.6.6 Data management and analysis  
Questionnaire data was collected electronically using digital tablets. All data collected 
through questionnaires and testing results were compiled and entered into STATA 14. 
Questionnaires were coded for double entry by the Information Technology Services at 
the Johns Hopkins Project. Each individual who agreed to participate was assigned a 
unique code. The database with data input from the questionnaires was analyzed using 
STATA version 14. Independent checks of range, validity, consistency and missing 
data was performed. Logic check programs were run to ensure that each value found in 
the data fell within the expected range or correspond to possible values in the 
codebook and the study coordinator resolved discrepancies.  
 
Key associations of interest involved investigating relationships between the 
occupational risk factor and the health outcomes. The key variables of interest are 
listed below. 
 
2.6.6.1 Dependent variables  
1. Symptom based definitions based on respiratory questionnaire were used in 
determining respiratory health outcomes:  
• Symptom based diagnosis of chronic bronchitis (COPD): Cough and 
sputum on most days lasting at least 3 months for two consecutive years 
• ECRHS Asthma definition: defined as either having shortness of breath in 
the past 12 months or an asthma attack in the past 12 months or current 
use of asthma medication  
• Asthma symptom score: An asthma symptom score was computed based 
on the sum of answers (0=no, 1=yes) to five questions on asthma-like 
symptoms in the past 12 months (short of breath while wheezing, woken 
up with chest tightness, attack of shortness of breath at rest, attack of 
shortness of breath after exercise, woken up by attack of shortness of 




• In addition Work-related chest symptoms and work-related nasal-ocular 
symptoms were also treated as outcomes of interest   
2. Results of lung function results were also used to define airway obstruction in 
respiratory health outcomes:  
A. FEV1<Lower Limit of Normal (LLN): Based on the Global Lung Initiative (GLI) 
equation 
B. FEV1<80%: this was based on the comparison with NHANES III reference 
values 
C. FEV1/FVC<LLN:  Based on the Global Lung Initiative (GLI) equation 
 
D. FEV1/FVC <70%: this was determined by using a standard cut-off of 70% for 
ratio 
E. Moderate to severe obstruction: defined as FEV1<80% and FEV1/FVC<70%  
 
2.6.6.2  Independent variables 
Nicotine exposure 
The main exposure variables for nicotine exposure were GTS symptoms, tasks 
involving contact with tobacco e.g. weeding, topping, harvesting, hanging tobacco, 
sorting, grading, stacking and related tasks. 
 
Pesticide exposure history  
These variables include working with pesticides, cleaning spraying equipment, working 
near pesticide applicators, getting into the field soon after spraying, pesticide drift into 
the home, use of tobacco pesticides at home, and related tasks. 
 
 
2.6.6.3  Confounding factors and covariates: 
Potential occupational covariates that were considered were host factors such as: age, 
gender, smoking status, family history of asthma, use of biomass fuel, HIV status and 
previous TB episode. 
 
2.6.7 Statistical analysis  
STATA statistical package version 14 was utilized for data management and calculating 




appropriate. Exploratory data analysis was carried out to highlight general features of 
the data that would guide further analysis. This included running descriptive checks that 
would reveal the number of observations, the type of variables, presence of outliers, the 
nature of data cleaning required and the extent of missing data as well as the 
distributions of the key variables. The data was then cleaned as required, missing 
variables labeled accordingly and outliers censored. Descriptive statistics were used to 
stratify the occupational groups and to analyze the independent variables amongst 
those groups. Univariate analyses were used to summarize the distribution of each 
measured variable. Exploratory bivariate analyses were used to assess the nature of 
the associations between exposures, outcomes and covariates. Multivariate regression 
analysis was applied to examine the association between the dependent and 
independent variables. Confounding and effect modification by covariates were 
considered in the formulation of the models. 
 
2.7 ETHICS 
The researcher sought approval from both the University of Cape Town Health 
Sciences Faculty Research Ethics Committee (HREC) as well as the Research Ethics 
Committee of the College of Medicine in Malawi (COMREC) and was carried out based 
on the following ethical principles: 
2.7.1 Autonomy 
An informed consent was sought after which individuals were free to participate or not 
at no associated cost. Appendix1. 
 
2.7.2 Confidentiality  
The research data for participants was treated with utmost confidentiality and 
communication of their test results were made directly to them. No personal identifiers 
were used and the information was not accessed by individuals who were not part of 
the investigating team. 
 
2.7.3 Benefit  
At individual level the participants were aware of their health outcomes and those with 
concerns were referred to their doctors. Furthermore, the findings of this research 
would help to inform appropriate measures for minimizing the burden of obstructive 





2.7.4 No harm 
We anticipated a negligible risk to arise during the course of the research to the 
participants except for discomfort coming from sample collections, spirometry, but they 
were allowed to withdraw where they experienced too much discomfort. Participants 
with abnormal findings were communicated with and counselled regarding their 
condition and where necessary the employer was advised with regard to workplace 
accommodation (with consent from the participant). 
 
2.7.5 Justice  
The growing concern of tobacco farmers’ exposure to pesticides and nicotine and 
scanty information about the effects on them justified carrying out this particular 
research in this population. It was anticipated that this would provide us with specific 
information that will inform recommended interventions needed to improve their working 
conditions to minimize health risk. 
2.8 RESEARCH FINDINGS AND DISSEMINATION OF RESULTS  
The findings from the study quantify the prevalence and burden of obstructive lung 
disease among tobacco farmers. It identifies and characterizes significant associations 
related to tobacco and pesticide exposure and other risk factors and will help to make 
informed decisions aimed at preventing and controlling obstructive lung diseases and 
their risk factors in this population. 
• It forms the basis of an MPhil dissertation 
• Conference presentations will be made  
• Publication in scientific journal 











CHAPTER 3: RESULTS 
 
3.1 Population and demographic characteristics 
A total of four farms were contacted with a total number of 759 seasonal perennial 
workers. Due to variations in farm activities during the calendar only about 60% of 
the population were called for duties during the study period which occurred during 
the spraying and topping season. All available employees were briefed about the 
survey and were to take part at the end of their shift by reporting to the 
administration offices where interviews and tests were conducted. A total of 281 
employees consented to participate. Of these, 279 completed the questionnaire 
while 276 attempted spirometry. Among those who consented for spirometry 258 
performed spirometry successfully while 18 did not complete. No participant had 
satisfied any exclusion criteria for spirometry among those who were interviewed. 
 
Table 3.1a: Study participation rate 
 Farm 1 Farm 2 Farm 3 Farm 4 
Total number of employees 
n=759 (%) 
350(46) 162(21) 167(22) 80(11) 
Consented to participate 
n=281 (% of particular farm population) 
183(52) 25(15) 35(21) 38(48) 
Interviewed  
n=279 (% of particular farm population) 
183(52) 23(14) 35(21) 38(48) 
Completed spirometry 
n=258 (% of particular farm population) 
173(49) 21(13) 31(19) 33(41) 
   
As seen from the table 3.1a above farm 1 and 4 had better participation rate than 
farms 2 and 3. The main reasons were farm logistics and employee engagement 
with supervisory staff. We observed that farms 1 and 4 had a good relation between 
supervisory staff and employees and it was easier to mobilize and address the 
employees than was the case with the other two farms.  
 
 
Data from the 279 farmers from all the four farms was analyzed. As shown in table 
3.1b below, the average age was 37.7±12.6 years and the majority were males 
(68%). Most of the participants (73%) had attained at least a primary education but 
there was a significant association between education and gender (p=0.000) with 





The majority of respondents were non-smokers (73%) with 20% current smokers 
while 7% had quit smoking. Cannabis use was prevalent among 5% of the farmers in 
this population. Alcohol use was reported by 42%. 
 
 
Among the participants, 16% of them were tested positive or reported a previous 
positive test for HIV. Some participants did not know their HIV status because they 
declined an offer to be tested and had not been tested before (18%). 
 
With respect to previous respiratory illness, 10% of the participants reported a history 
of repeated childhood chest infections, 4% reported a t history of previous pulmonary 




Table 3.1b: Demographic characteristics of tobacco farmers in Malawi 
 
 
















     





Home Language     0.637 
- Lhomwe 123(44) 87 (46) 36 (40)  
- Yao 40(14) 28 (14) 12 (13)  
- Sena 1(0.3) 1 (1) 0  
- Chichewa 0(0) 0 0  
- Other 115(41) 73 (39) 42 (47)  
Education    0.000 
- None 30(11) 9 (4.8) 21 (23.3)  
- Lower primary 86(31) 49 (25.9) 37 (41.1)  
- Upper primary 117(42) 87 (46.0) 30 (33.3)  
- Secondary  46(16) 44 (23.3) 2 (2.2)  
Smoking status: n (%)     
- Current smokers 57(20) 39 (20.6) 18(20.0) 0.902 
- Ex-smokers 19(7) 15(8) 4(4) 0.279 
- Never smokers 203(73) 135(71) 68(76) 0.469 
Cannabis use  14(5) 10(5) 4(4) 0.762 
     
Alcohol  118(42) 
 
82(43) 36(40) 0.593 
- Ever felt need to 
reduce alcohol 
84(30) 55(29) 29(32) 0.595 
- Ever felt guilty due 
to drinking 
72(26) 49(26) 23(26) 0.947 
- Ever criticized of 
drinking  
56(20) 38(20) 18(20) 0.984 




29(15) 15(17) 0.777 
HIV status    0.115 
- Negative (reported 
or tested) 
184(66) 132 (69.4) 52 (57.8)  
- Positive (reported or 
tested) 
44(16) 25 (13.2) 19 (21.1)  
- Unknown 51(18) 32 (16.9) 19 (21.1)  
Past medical history      
- Repeated childhood 
chest infections   
29(10) 23(12) 6(7) 0.159 
- Previous TB 
episode  
10(4) 7(4) 3(3) 1.000 
- Chronic bronchitis  9(3) 7(4) 2(2) 0.723 




3.2 Farm and occupational characteristics 
 
Participants were drawn from, four tobacco farms with an annual production ranging 
from 80 to 250 tones (Table 3.2a). The main type of tobacco cultivated was the flue 
cured variety which was handled by 99 percent of the participants. The other 
reported varieties were Burley and Northern Division Dark Fire-Cured (NDDF). Two 
thirds of respondents came from the largest farm among the four due to logistical 
issues and accessibility of the farmers. 
 

















Farm 1 210 250 350 183(66) 124(66) 59(66) 
Farm 2 132 150 162 23(8) 20(11) 3(3) 
Farm 3 90 110 167 35(13) 27(14) 8(9) 




The median duration of employment for the farmers was 5 years with a significantly 
lower duration of 4 years among females than males (5 years). Among the 
respondents 62% reported working mainly with tobacco, 20% of the workers worked 
mainly with pesticides in their job, 4% were supervisors while the rest did some 
construction related work such as wielding, building and plumbing. About 28% of the 
workers indicated to handle both tobacco and pesticides in their job tasks regardless 
of their job description. Only 22% of the farmers reported use of protective 
equipment at work while 20% indicated that their protective equipment is provided by 
the employer for free. The main task for which protective equipment was worn was 
spraying of chemicals as reported by 15% of the respondents. Masks, aprons, 
gloves and goggles were the commonly used protective equipment (Table 3.2b). 








Table 3.2b: Workplace characteristics 
*Presented as median and interquartile range 
 
3.3 Respiratory symptoms 
 
As shown in table 3.3 the prevalence of those who reported to ever have asthma 
was 8% with the majority having their asthma before age of 17 (88%). There was a 
significant association between childhood asthma and gender with more males 




(%) n =279 
Baseline 
Prevalence 




(%) n =90 
Females 
p-value 
Types of tobacco cultivated      
Flue cured  276(99)    
Burley- air-cured 5(2)    
Northern division dark fire-cured 
(NDDF) 
1(0.0)    
     
Types of job    0.671 
- Tobacco handler 174(62) 118(63) 56(62)  
- Chemical handler 56(20) 40(21) 16(18)  
- Supervisor  10(4) 5(3) 5(5)  
- Other (plumbing, building, 
cooking, welder) 
37(13) 24(13) 13(15)  
Work with tobacco & pesticides 77(28) 56(30) 21(23) 0.271 
Employment duration* 5 (2-10) 5 (2-10) 4 (2-8) 0.031 
     
Availability of washrooms at 
workplace 
172(62) 113(60) 59(68) 0.239 
Availability of handwashing facilities 
at workplace 
40(14) 23(12) 17(20) 0.114 
     
Personal Protective Equipment 
(PPE) use  
61(22) 44(23) 17(19) 0.407 
Tasks during which PPE is used      
- Spraying  43(15) 32(17) 11(12) 0.538 
- Curing 12(4) 9(5) 3(3) 1.000 
- Sorting 5(2) 2(1) 3(3) 0.181 
- Tilling 4(1) 3(2) 1(1) 1.000 
- Harvesting  3(1) 2(1) 1(1) 1.000 
- Sowing, Transplant, weeding 2(1) 2(1) 0 0.327 
- Stacking  2(1) 1(1) 1(1) 0.483 
- Cleaning equipment 
(including PPE) 
2(1) 2(1) 0 0.489 
- Other tasks including 
transport, administration 
14(5) 10(5) 4(4) 0.876 
     
PPE regularly for at least a year     
- Mask 44(16) 31(16) 13(14) 0.675 
- Gloves 37(13) 26(14) 11(12) 0.724 
- Apron 20(7) 14(7) 6(7) 0.823 
- Goggles 20(7) 13(7) 7(8) 0.785 
- Others (boots) 9(3) 8(4) 1(1) 0.168 
Free provision of PPE by 
employer 




reporting childhood asthma than females. Using an ECRHS definition 20% of 
respondents met the criteria for possible current asthma whilst 23% had an asthma 
score of ≥2 in keeping with a diagnosis of possible asthma. The prevalence of 
asthma related symptoms in the past 12 months ranged from 8% to 30% with the 
most common symptoms being reported as shortness of breath following exercise 
(30%); attacks of wheezing (19%); shortness of breath and wheezing (19%) and 
shortness of breath during daytime (18%).  
 
The prevalence of childhood hay fever was 6%. Nasal-ocular symptoms were 
reported by 29% of the respondents. Additionally, eye symptoms were shown to 
significantly affect more females than males, 28% and 16%, respectively. 
 
COPD prevalence was 17% based on a standard definition although 10-33% of 






















Asthma history     
Ever had asthma (self-reported known) 23(8) 19(10) 4(4) 0.111 
Asthma at ≤ 16 years 19(7) 17(9) 2(2) 0.036 
Asthma > 16 years 3(1) 1(1) 2(2) 0.200 
Current Asthma (ECRHS definition) 55(20) 40(21) 15 0.377 
Woken up by an attack of shortness of breath in the last 12 
months 
50(18) 35(19) 15(17) 0.706 
Asthma attack in the past 12 months 9(3) 8(4) 1(1) 0.168 
Current use of asthma medication 3(1) 2(1) 1(1) 0.968 
Doctor-diagnosed asthma 4(1) 3(2) 1(1) 0.754 
Childhood hay fever  16(6) 12(6) 4(4) 0.522 
Childhood asthma 19(7) 17(9) 2(2) 0.036 
Asthma-related symptoms     
Ever had attacks of wheezing (wheezing in the past) 68(24) 47(25) 21(23) 0.780 
Wheezing in the past 12 months 54(19) 38(20) 16(18) 0.645 
Shortness of breath while wheezing in the last 12 months  54(19) 38(20) 16(18) 0.645 
Wheezing or whistling without cold / flu symptoms  40(14) 29(15) 11(12) 0.487 
Woken up with chest tightness in the last 12 months 23(8) 16(8) 7(8) 0.845 
Attack of shortness of breath at rest during daytime in the last 12 
months 
50(18) 35(19) 15(17) 0.706 
Attack of shortness of breath following running or exercise in the 
last 12 months 
83(30) 54(29) 29(32) 0.533 
Asthma symptom score*    0.754 
Asthma Score of 0-1 214(77) 146(77) 68(76)  
Asthma Score of 2-5 65(23) 43(23) 22(24)  
Upper airway symptoms     
Presence of nasal-ocular symptoms ever 82(29) 50(26) 32(36) 0.119 
≥2 episodes in past 12 months      
- Nasal 36(13) 21(11) 15(17) 0.196 
- Eyes 56(20) 31(16) 25(28) 0.027 
COPD symptoms History     
Woken up by attack of cough or phlegm in last 12 months  91(33) 60(32) 31(34) 0.653 
Usual cough first thing in morning  61(22) 39(21) 22(24) 0.472 
Day / night cough  55(20) 35(19) 20(22) 0.467 
Cough on most days / nights for 3 or more months a year in each 
of last 2 years  
36(13) 22(12) 14(16) 0.362 
Phlegm on most days / nights for 3 or more months a year in each 
of last 2 years  
28(10) 17(9) 11(12) 0.402 
Chronic bronchitis: Cough or phlegm on most days / nights for 3 
or more months a year in each of last 2 years 
48(17) 29(15) 19(21) 0.233 
Phlegm first thing in morning  52(19) 32(17) 20(22) 0.289 
Day/ night phlegm 46(16) 26(14) 20(22) 0.075 
Trouble with breathing  52(19) 36(19) 16(18) 0.799 
- rarely  33(12) 23(12) 10(11)  
- repeatedly 14(5) 10(5) 4(4)  
- continuously 5(2) 3(2) 2(2)  
*Asthma symptom score: An asthma symptom score was computed based on the sum of answers (0=no, 1=yes) 
to five questions on asthma-like symptoms in the past 12 months (short of breath while wheezing, woken up with 
chest tightness, attack of shortness of breath (SOB) at rest, attack of shortness of breath after exercise, woken 
up by attack of shortness of breath)  
#Current asthma attack of SOB in the last 12 months or asthma attack in the last 12 months or current use of 






3.4 Work-related respiratory symptoms 
 
The respondents demonstrated a higher prevalence of work- related chest 
symptoms (29%) with 11% reporting an episode of high exposure at work as causing 
respiratory symptoms. Reported causes of the work related chest symptoms were 
exposure to dried tobacco (12%), smoke from fires (5%), soil dust (5%), pesticides 
(4%) and farming in the field (4%). A few (4%) of the respondents reported switching 
jobs due to chest symptoms.  
 
Work related nasal-ocular symptoms were less common (20%) and were caused by 
exposure to pesticides (8%), soil dust (5%) and dried tobacco (4%). Table 3.4. No 




Table 3.4: Work-related symptoms reported by tobacco farmers in Malawi 
Symptom Baseline 
Prevalence 








Work-related chest symptoms      
Episode of high exposure at work 
causing tight chest, shortness of 
breath, wheeze or cough   
30(11) 19(10) 11(12) 0.585 
Work-related chest symptoms 
(ever) a 
80(29) 58(31) 22(24) 0.281 
Job change due to work-related 
chest symptoms 
10(4) 9 (5) 1(1) 0.125 
     
Common causes of chest 
symptoms 
   0.337 
- Dried tobacco 33(12) 21(11) 12(13)  
- Dust (soil) 15(5) 10(5) 5(6)  
- Smoke from fire 13(5) 10(5) 3(3)  
- Pesticides 12(4) 11(6) 1(1)  
- Farming in the field 10(4) 9(5) 1(1)  
     
Work-related upper airway 
symptoms 
    
Work-related nasal-ocular 
symptoms  
57(20) 33(17) 24(27) 0.075 
     
Causes of nasal-ocular 
symptoms  
  0.814 
- Pesticides 22(8) 14(7) 8(9)  
- Dust (soil) 14(5) 9(5) 5(6)  
- Dried tobacco 11(4) 6(3) 5(6)  
- Fresh tobacco 3(1) 2(1) 1(1)  
- Farming in the field 2(1) 1(1) 1(1)  





3.5 Exposure to biomass fuel 
 
Table 3.5 demonstrates the environmental and occupational exposure to biomass 
fuel. Most of the farmers (87%) had daily exposure to biomass fuel for an average of 
3 hours. The prevalence of work- related exposure only was 17% while 42% are 
exposed to biomass fuel at home only, with27% of the farmers reporting a combined 
exposure to biomass at home and work. The main fuel used was firewood and the 
two main tasks associated with biomass fuel exposure were cooking (78%) and 
curing of tobacco (44%). There was no observed significant association between 
exposure to biomass fuels and gender. 
 
 
Table 3.5: Biomass fuel exposure of tobacco farmers in Malawi  
 
*Presented as median and interquartile range 
 
3.6 Nicotine exposure 
 
The presence of green tobacco sickness (GTS) was used as a proxy for acute 
nicotine exposure and toxicity. The prevalence of GTS in the previous year was 26% 
and participants reported an average of 3 episodes occurring in that period. The 














Biomass fuel      
Exposed to biomass fuels 242 (87) 166(88) 76(84) 0.436 
- Home only 118(42) 85(45) 33(37) 0.218 
- Work only 48 (17) 34(18) 14(16) 0.615 
- Both home and work 76(27) 47(25) 29(32) 0.197 
Main source    0.499 
- Firewood 241(86) 165(87) 76(84)  
- Charcoal  1 (0) 1(1) 0  
- Coal 0(0) 0 0  
- Other 0(0) 0 0  
Main tasks exposing to 
environmental smoke at 
home/work or both 
    
- Cooking 218(78) 147(78) 71(79) 0.834 
- Curing (flue) 123(44) 79(42) 44(49) 0.305 
- Smoke from tobacco 13(5) 8(4) 5(6) 0.476 
- Other 1(0.0) 1(1) 0 0.489 
Frequency of exposure to 
biomass*  
    
- Hours per day(IQR) 3(2-6) 3(2-6) 3(2-6) 0.478 
-  Days per month(IQR) 30(30-30) 30 (30-30) 30(30-30) 0.067 
-  Months per year(IQR) 12(12-12) 12(12-12) 12(12-12) 0.638 
-  Days per year (IQR) 365(360-365) 365(360-365) 365(365-365) 0.171 




nausea were the commonly reported symptoms, 29% and 17% respectively. Nausea 
and vomiting were significantly higher among males than females while the rest of 
the symptoms did not show any association with gender. Harvesting, curing, and 
sowing were the key tasks that were linked to GTS symptoms. 
 
 
Table 3.6: Nicotine exposure of tobacco farmers in Malawi  
 
‡ presented as mean and standard deviation 
 
 
3.7  Pesticides exposure  
 
Table 3.7 outlines the participants’ exposure characteristics to pesticides. More 
than half (57%) of the farmers reported application of pesticides in their job for 
approximately 1 hour per day for 60 days a year. Many of the farmers (72%) 
reported pesticide exposure during spraying and 83% re-entered the fields soon 
after spraying pesticides. The commonest pesticides used were 
organophosphates (18%) followed by copper (15%), and pyrethroids (8%). About 













Nicotine exposure      
GTS symptoms ever  98(35) 69(37) 29(32) 0.483 
GTS Symptoms in past 12 
months  
73(26) 53(28) 20(22) 0.301 
GTS Symptoms     
- Headache  81(29) 53(28) 28(31) 0.598 
- Nausea 47(17) 38(20) 9(10) 0.035 
- Dizziness 29(10) 21(11) 8(9) 0.570 
- Vomiting    16(6) 15(8) 1(1) 0.022 
How many episodes of GTS in 
the last 12 months‡ 
3.2±1 3.1(2) 3.5 0.181 
How soon after work did 
symptoms occur  
   0.582 
- Same day 67(24) 49(26) 18(20)  
- Day after 6(2) 3(2) 3(3)  
- 2 days after 7(3) 6(3) 1(1)  
- 3 days after 4(1) 3(2) 1(1)  
- A week after 14(5) 8(4) 6(7)  
Farm activities associated with 
GTS symptoms  
    
- Harvesting 50(18) 32(17) 18(20) 0.532 
- Curing               
31(11) 
18(10) 13(14)    0.221 
- Sowing  28(10) 21(11) 7(8) 0.386 
- Transplanting  23(8) 15(8) 8(9) 0.787 
- Other (uprooting, 
planting, grading) 
30(11) 25(13) 5(6) 0.053 




pesticides (15%) and other domestic pesticides (39%). Farmers also indicated 








* *Presented as median and interquartile range 














Pesticide exposure      
Pesticides application 158(57) 111(59) 47(52) 0.305 
Work near pesticides sprayers 200 (72) 135(71) 65(72) 0.891 
- #Number of days worked in 
the field near sprayers 
while pesticides are 
applied per season  
14.0±22 
 
13.8±19 14.5±27 0.820 
*Frequency of pesticide use 
among 
    
- Hours per day(IQR) 1(1-1) 1(1-1) 1(1-1) 0.885 
- Days per month(IQR) 24(12-30) 24(8-30) 24(12-30) 0.996 
- Days per year use 
pesticides(IQR) 
60(30-120) 60(30-150) 60(30-100) 0.403 
Pesticide types     
- Organophosphates 49(18) 36(19) 13(14) 0.345 
- Copper 42(15) 30(16) 12(13) 0.406 
- Pyrethroids 23(8) 18(10) 5(6) 0.260 
- Neonicotinoids 4(1) 3(2) 1(1) 0.754 
- Herbicides  3(1) 3(2) 0 0.229 
- Other (decanol, benomyl, 
pyraclostrobin, fluopyram) 
48(32) 34(18) 14(16) 0.406 
Exposure during spraying 45 (16) 26(14) 19(21) 0.118 
Pesticide drift 22 (8) 12(6) 10(11) 0.168 
Field re-entry soon after spraying 232 (83) 158(84) 74(82) 0.774 
Home use of pesticides 142 (51) 94(50) 48(53) 0.574 
Types of pesticides used at home     
o Tobacco pesticides used 
at home 




104(37) 68(36) 36(40) 0.760 
- Pesticides for tomato 
plants (not specified) 
1(0.0) 1(1) 0  
- Maize pills 1(0.0) 1(1) 0  
- Servin (carbamate) 1(0.0) 1(1) 0  






3.8 Pulmonary function tests 
 
Spirometry results were available for 258 participants and were interpreted using 
NHANES and Global Lung Initiative (GLI) criteria.  The median FEV1 was 
2.64L(2.15L-3.13L) and showed a significant association with gender with female 
indices lower compared to males. Using NHANES references, 20% of the 
participants had an FEV1 below 80% of the predicted value suggesting an element 
of airflow limitation. When GLI equations were used to determine those with 
FEV1<LLN the prevalence was 31% and showed significant association with gender 
with a higher proportion of females affected. The median ratio (FEV1/FVC) was 
80.89 (IQR: 76.03-85.23) which was within the normal range with 8% of the 
respondents having a ratio of less than 70% suggestive of airway obstruction.  
 
Using GLI criteria, 31% had an FEV1 < LLN and 28% had an FVC<LLN, with 14% 
having an FEV1/FVC<LLN in keeping with possible airflow limitation. The median 
percentage of predicted values for FEV1 and FVC were higher when using NHANES 
than when using GLI, 95% and 96% versus 86% and 89%, respectively.  
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2.64 (2.15 – 
3.13) 
2.93 (2.43-3.32 2.1 (1.83-
2.40) 










3.59 (3.12-3.99) 2.62 (2.37-
2.92) 







































FEV1< LLN     80(31) 48(27) 32(41) 0.036 
FEV1< 80% 
pred. 
51(20) 35(20) 16(20) 0.950 91(35) 55(31) 36(46) 0.028 
FVC < LLN     72(28) 45(25) 27(34) 0.161 
FVC < 80% 
pred. 


















FEV1 /FVC < 
LLN 
    35(14) 27(15) 8(10) 0.262 
FEV1 /FVC < 
70% 
21(8) 17(9) 4(5) 0.216 21(8) 17(9) 4(5) 0.216 
         
FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; L: litres; LLN: Lower limit of normal; 
IQR: interquartile range; % pred: % predicted; *: pre-bronchodilator values, unless stated otherwise; GLI:Global lung function initiative reference values; 
NHANES: National Health And Nutrition Examination Survey III reference values 
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Table 3.9: Summary of Health Outcomes 
 
  
Current asthma: yes to any of the 3 questions: Woken up by an attack of shortness of breath in the 







Males Females  p-value 
Work related Chest 
symptoms 
80(29%) 58(31) 22(24) 0.281 
Work related Ocular and 
nasal symptoms 
57 (20%) 33(17) 24(27) 0.075 
Asthma (clinical)     
Current asthma  55 (20%) 40(21) 15(17) 0.377 
Asthma symptom 
score≥2 
65 (23%) 43(23) 22(24) 0.754 
COPD (clinical) 48 (17%) 29(15) 19(21) 0.233 
Airway obstruction     
FEV1 < LLN (GLI) 80 (31%) 48(27) 32(41) 0.036 
FEV1<80% predicted 
NHANES 
51 (20%) 35(20) 16(20) 0.950 
FEV1/FVC <LLN (GLI) 35 (14%) 27(15) 8(10) 0.262 
FEV1/FVC<70%  21 (8%) 17(9) 4(5) 0.216 
Fev1<80% and 
FEV1/FVC<70% 
(Moderate to severe 
obstruction) 
11 (4%) 9(5) 2(3) 0.347 
 




3.9 Demographic and host characteristics as predictors of respiratory 
outcomes  
Regression model development  
The univariate models were developed based on known risk factors from literature 
as well as the perceived risk factors in the hypothesis. The risk factors were 
separately grouped into demographics and past medical history; proxies for nicotine 
exposure; proxies for pesticides exposure; and proxies for biomass fuel exposure.  
 
Multivariate models were developed using the saturated model adjusted for known 
risk factors document in literature i.e. age, gender, smoking and childhood chest 
infections. The biomass variable was left out in the adjustment as this was noted to 
be a universal exposure for  almost all workers on the farm. The selected 
confounders were entered together into the model in each entry for every proxy of 
exposure. This was done to allow for comparisons with findings from other studies. 
 
Unadjusted analysis  
The association between demographic characteristics and respiratory outcomes is 
outlined in table 3.11a and 3.11b. Analysis is shown for both symptom-based and 
spirometry- based outcomes .  
Age and gender were not significantly associated with any respiratory symptom-
based outcomes. There was an increased significant association between female 
gender and a low FEV1(FEV1<LLN) (OR 1.81, CI 1.03-3.15, p<0.05). Attaining a  
secondary school education was associated with increased reporting of asthma 
symptoms in both current asthma  (OR 4.94, CI 1.02-23.95, p<0.05) and asthma 
score≥2  (OR 3.94, CI 1.02-15.16, p<0.05) but this was  not significantly associated 
with  spirometry based diagnoses. 
There were no significant associations between smoking, alcohol use and drug use 
with respiratory outcomes as outlined in table 3.11a and 3.11b.  
The association between HIV infection, previous TB, past chest infections, childhood 
bronchitis and respiratory outcomes is outlined below in table 3.10a and 3.10b. A 
history of past chest infections during childhood  showed an increased  and 
significant association with current asthma OR 2.86, CI 1.26 – 6.48, p<0.05), asthma 
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score≥2 (OR 3.64, CI 1.65-8.03, p<0.01), WRCS (OR 3.05, CI 1.40-6.66, p<0.0.01), 
and COPD (OR 3.52, CI 1.54-8.05, p<0.01).  
For the spirometry-based outcomes past chest infections showed a significantly  
increased risk for  FEV1<80% (OR 2.41, CI 1.04-5.57, p<0.05). HIV infection, 
previous TB, and childhood bronchitis did not show any significant association with 
both symptom-based and spirometry-based respiratory outcomes.   
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Table 3.10a: Predictors of symptom-based asthma and COPD diagnoses (unadjusted regression analysis)  
     Asthma score≥2 Current Asthma  COPD Symptoms  Work related ocular Work related    
nasal symptoms     chest symptoms 
Predictors  n=279  n=65   n=55   n=48   n=57   n=80 
HOST  
 
Age     0.99 (0.97-1.01)  0.99 (0.96 – 1.01) 1.00 (0.98-1.03)  1.01 (0.99-1.03)  0.99 (0.97-1.01)  
Gender   
-Male      1.00   1.00   1.00   1.00   1.00   
-Female    1.10 (0.61-1.98)  0.75 (0.39 – 1.43) 1.48 (0.78-2.81)  1.72 (0.94-3.13)  0.73 (0.41-1.29)  
Smoking 
- non-smoker   1.00   1.00    1.00   1.00   1.00    
- ex-smoker   2.48 (0.94-6.54)  2.62 (0.96 – 7.10) 1.30 (0.15-11.04) 1.41 (0.48-4.14)  2.25 (0.87-5.82)  
- smoker    0.82 (0.39-1.70)  1.07 (0.51 – 10.32) 0.83 (0.17-4.05)  0.94 (0.45-1.98)  0.74 (0.37-1.47)  
 
Education 
- None   1.00   1.00   1.00   1.00   1.00    
- Lower primary  3.29 (0.91-11.87) 3.71 (0.81 – 17.04) 1.72 (0.53-5.57)  2.05 (0.70-5.96)  1.94 (0.66-5.64)   
- Upper primary  2.45 (0.69-8.73)  3.43 (0.76 – 15.43) 1.03 (0.32-3.34)  0.91 (0.31-2.69)  2.05 (0.72-5.79)  
- Secondary  3.94 (1.02-15.16)* 4.94 (1.02 – 23.95)* 1.81 (0.51-6.39)  1.22 (0.36-4.06)  2.93 (0.95-9.09)  
 
Drug use    2.62 (0.87-7.85)  1.68 (0.51-5.57)  1.33 (0.36-4.97)  0.29 (0.04-2.24)  1.41 (0.46-4.34)  
HIV-infected (n=228)   0.57 (0.24-1.36)  0.73 (0.30 – 1.76) 0.65 (0.25-1.65)  0.68 (0.28-1.64)  0.54 (0.25-1.21)  
Alcohol use† (n=118)  2.37 (0.88-6.41)  1.82 (0.66 – 5.01) 1.70 (0.62-4.69)  0.48 (0.19-1.21)  2.50 (0.98-6.39)   
History chest infection  3.64 (1.65-8.03)** 2.86 (1.26 – 6.48)* 3.52 (1.54-8.05)** 1.89 (0.81-4.42)  3.05 (1.40-6.66)**  
Previous TB    0.36 (0.04-2.86)  1.79 (0.45 – 7.15) -    0.42 (0.05-3.41)  1.69 (0.46-6.17)   
Childhood bronchitis   2.74 (0.71-10.52) 3.44 (0.89 – 13.25) 1.39 (0.28-6.91)  1.12 (0.23-5.53)  0.30 (0.04-2.46)  
_____________________________________________________________________________________________________________________________ 
Each entry represent a separate univariate regression between each predictor and each outcome 
*= p≤0.05; **=p≤0.01; ***=p≤0.001;   † Cage Score; Define positive score ≥2/4 positive responses to CAGE questions on problem drinking  
 Current asthma: yes to any of the 3 questions: Woken up by an attack of shortness of breath in the last 12 months or Asthma attack in the past 12 months or Current use of 
asthma medication 
Asthma Score category*Asthma symptom score: An asthma symptom score was computed based on the sum of answers (0=no, 1=yes) to five questions on asthma-like 
symptoms in the past 12 months (short of breath while wheezing, woken up with chest tightness, attack of shortness of breath at rest, attack of shortness of breath after 
exercise, woken up by attack of shortness of breath). Positive if yes to ≥2 questions  
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Table 3.10b: Predictors of spirometry-based airway obstruction diagnoses (unadjusted regression analysis)  
     FEV1<LLN  FEV1/FVC<LLN  FEV1<80%‡  FEV1/FVC<70%‡  Moderate/Severe 
                Obstruction 
Predictors n=258  n=80   n=35   n=51   n=21   n=11 
HOST  
Age     0.99 (0.97-1.01)  1.01 (0.98-1.04)  0.99 (0.97-1.02)  1.04 (1.00-1.07)  1.03 (0.99-1.07) 
 
Gender   
-Male      1.00   1.00   1.00   1.00   1.00   
-Female    1.81 (1.03-3.15)* 0.62 (0.27-1.44)  1.02 (0.53-1.98)  0.50 (0.16-1.53)  0.48 (0.10-2.28) 
 
Smoking 
- non-smoker    1.00   1.00   1.00   1.00   1.00 
- ex-smoker   1.18 (0.42-3.31)  1.41 (0.38-5.24)  0.89 (0.24-3.24)  2.27 (0.59-8.72)  1.30 (0.15-11.04) 
- smoker   1.25 (0.66-2.36)  1.38 (0.60-3.18)  1.52 (0.74-3.09)  0.65 (0.18-2.35)  0.83 (0.17-4.05) 
     
Education 
- None   1.00   1.00   1.00   1.00   1.00 
- Lower primary  0.72 (0.28-1.86)  0.65 (0.18-2.35)  1.12 (0.37-3.41)  0.66 (0.15-2.83)  1.03 (0.10-10.30) 
- Upper primary  1.18 (0.48-2.87)  1.31 (0.41-4.20)  1.26 (0.43-3.67)  0.91 (0.23-3.51)  1.53 (0.18-13.27) 
- Secondary  0.59 (0.20-1.71)  0.42 (0.09-2.05)  0.69 (0.19-2.54)  0.19 (0.02-1.89)  0.60 (0.04-10.09) 
 
Drug use    1.72 (0.58-5.14)  1.81 (0.48-6.82)  0.66 (0.14-3.06)  1.97 (0.41-9.47)  1.8 (0.21-15.15) 
HIV-infected (n=212)  1.49 (0.73-3.05)  0.87 (0.31-2.44)  1.10 (0.48-2.53)  0.82 (0.23-2.96)  1.11 (0.23-5.47) 
Alcohol use† (n=110)  1.47 (0.63-3.44)  1.37 (0.40-4.70)  2.37 (0.81-6.94)  1.06 (0.18-6.06)  - 
History chest infection  1.20 (0.53-2.70)  1.38 (0.49-3.90)  2.41 (1.04-5.57)* 1.35 (0.37-4.91)  3.19 (0.80-12.77) 
Previous TB    0.54 (0.11-2.63)  0.70 (0.09-5.70)  -   -   - 
Childhood bronchitis   1.82 (0.48-6.97)  0.79 (0.10-6.52)  1.17 (0.23-5.79)  1.43 (0.17-12.03) -
_______________________________________________________________________________________________________________________ 
Each entry represent a separate univariate regression between each predictor and each outcome 
 *= p≤0.05; **=p≤0.01; p=≤0.001;  † Cage Score;  FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; LLN: Lower limit of normal;  
‡NHANES: National Health And Nutrition Examination Survey III reference values 
† Cage Score; Define positive score ≥2/4 positive responses to CAGE questions on problem drinking  
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3.10 Pesticide exposure as a predictor of respiratory outcomes 
 
The association between pesticide exposure and work-related symptoms, asthma 
and COPD symptoms, as well as lung function is outlined in table 3.11a and 3.11b. 
The unadjusted logistic regression models showed a significant increased 
association between pesticides application with current  asthma (OR 2.14, CI 1.14 – 
4.07, p<0.05), asthma score ≥2 (OR 2.42, CI 1.32-4.44, p<0.01), COPD (OR 2.36, CI 
1.19-4.70, p<0.05), as well as ocular nasal symptoms (OR 1.88, CI 1.01-3.48, 
p<0.05). Pesticides exposure during spraying was associated with increased risk for 
asthma score (OR 2.35, CI 1.19-4.65, p<0.05,) current asthma (OR 2.76, CI 1.37 – 
5.56, p<0.01) and WRONS (OR 2.60, CI 1.29-5.22, p<0.01). Participants who 
reported that  pesticides  drift had an increased risk for current asthma (OR 2.55, CI 
1.01 – 6.44, p<0.05), asthma score ≥2 (OR 2.48, CI 1.01-6.11, p<0.05) and WRONS 
(OR 3.01, CI 1.22-7.46, p<0.05). Re-entering the field soon after spraying was also 
associated with increased risk for COPD 5.56 (1.30-23.79)* symptoms and 
decreased risk for ocular nasal symptoms (OR 0.47, CI 0.23-0.95, p<0.05). 
Additionally, there was a significant association showing increased risk between 
duration of exposure to pesticides and WRONS (OR 8.34, CI 2.73-25.54, p<0.001). 
 
Table 3.11b shows that there was an increased risk of airflow limitation reflected in 
significant associations between duration of exposure to pesticides with 
FEV1/FVC<LLN (OR 3.97, CI 1.38-11.40, p<0.05), FEV1/FVC<70% (OR 3.89, CI 
1.30-11.36, p<0.05), and moderate to severe airway obstruction (OR 5.12, CI 1.53-
17.16, p<0.01). Additionally, using pesticides at home was significantly associated 
with a decreased risk for having a lower lung ratio (FEV1/FVC<LLN) (table 3.12b).. 
 
3.11 Nicotine exposure as a predictor of respiratory outcomes 
 
The association between nicotine exposure and work related symptoms, asthma and 
COPD symptoms, as well as lung function is outlined in table 3.11a and 3.11b. The 
unadjusted logistic regression models show that having reported a history of a GTS 
episode was significantly associated with all symptom-based diagnoses (OR ranging 
from 2.12 to 6.93, p<0.05 to p<001 ).  
Certain tasks like sowing and transplanting were significantly associated with all 
respiratory symptoms (OR ranging from 2.48 to 6.26, p<0.001 to p<0.05). Harvesting 
was significantly associated with WRCS (OR 2.57, CI 1.37-4.83, p<0.01), WRONS 
(OR 7.79, CI 3.96-15.30, p<0.001), COPD symptoms (OR 2.23, CI 1.09-4.57, 
p<0.05), Current asthma  (OR 2.03 CI 1.01 – 4.06, p<0.05), but not significantly with 
asthma score. Curing showed an increased significant strong association with 
WRONS (OR 18.10 CI 7.49-43.72, p<0.001) only.  
There were no significant associations between nicotine exposure variables and lung 
function indices. 
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Table 3.11a: Predictors of symptom-based asthma and COPD diagnoses (unadjusted regression analysis) related to Exposures  
_________________________________________________________________________________________________________________- 
                 Asthma score≥2 Current Asthma COPD Symptoms  Work related ocular Work related    
nasal symptoms     chest symptoms 
Predictors n=279   n=65   n=55   n=48   n=57   n=80 
 
Nicotine Exposure  
Previous GTS episode      2.80 (1.58-4.94)*** 3.03 (1.65 – 5.54)*** 2.12 (1.13-3.98)* 5.4 (2.89-10.09)*** 3.82 (2.22-6.59)***  
GTS episode in past year   3.41 (1.88-6.16)*** 3.73 (2.01 – 6.94)***  2.68 (1.40-5.12)** 6.93 (3.67-13.05)*** 3.30 (1.87-5.80)***  
Activities related to GTS  
- Sowing   3.92 (1.76-8.75)** 5.12 (2.27 – 11.55)***  5.35 (2.35-12.19)*** 4.84 (2.15-10.88)*** 2.80 (1.27-6.19)*  
- Transplanting   4.18 (1.75-10.00)**    2.93 (1.20 – 7.19)* 5.43 (2.23-13.20)*** 6.26 (2.58-15.19)*** 2.48 (1.05-5.89)*  
- Harvesting  1.94 (1.00-3.78)   2.03 (1.01 – 4.06)* 2.23 (1.09-4.57)* 7.79 (3.96-15.30)*** 2.57 (1.37-4.83)**  
- Curing    1.98 (0.89-4.38)  2.15 (0.95 – 4.87) 1.81 (0.76-4.33)  18.10 (7.49-43.72)*** 1.67 (0.77-3.63)   
Other    3.98 (1.82-8.68)** 3.19 (1.43 – 7.11)** 1.54 (0.62-3.84)  0.76 (0.28-2.08)  4.52 (2.06-9.92)***  
Pesticide Exposure (279) 
Workplace Pesticides application 2.42 (1.32-4.44)** 2.15 (1.14 – 4.07)* 2.36 (1.19-4.70)* 1.88 (1.01-3.48)* 1.63 (0.95-2.79)  
-Duration in Hrs/day (158)              1.01 (0.71-1.42) 0.84 (0.46 – 1.54) 1.12 (0.81-1.56)  8.34 (2.73-25.54)*** 0.97 (0.68-1.39)  
Work near pesticide sprayers     1.15 (0.62-2.16) 1.07 ( 0.55 – 2.06) 1.88 (0.87-4.10)  0.67 (0.36-1.24)  1.06 (0.59-1.89)  
Environmental    
Exposure during spraying    2.35 (1.19-4.65)* 2.76 ( 1.37 – 5.56 )** 1.47 (0.67-3.23)  2.60 (1.29-5.22)** 1.65 (0.84-3.21)   
Pesticide drift      2.48 (1.01-6.11)* 2.55 (1.01 – 6.44)* 1.46 (0.51-4.18)  3.01 (1.22-7.46)* 1.81 (0.74-4.43)   
Field re-entry after spraying   2.33 (0.94-5.77) 1.49 (0.63 – 3.54) 5.56 (1.30-23.79)* 0.47 (0.23-0.95)* 1.21 (0.59-2.47)   
Home use of pesticides)   1.49 (0.85-2.61)  1.31 ( 0.73 – 2.38) 1.30 (0.69-2.43)  0.64 (0.36-1.15)  0.95 (0.57-1.60)   
  
Each entry represent a separate univariate regression between each predictor and each outcome 
*= p≤0.05; **=p≤0.01; ***=p≤0.001;  
Current asthma: yes to any of the 3 questions: Woken up by an attack of shortness of breath in the last 12 months or Asthma attack in the past 12 months or Current use of 
asthma medication 
Asthma Score category*Asthma symptom score: An asthma symptom score was computed based on the sum of answers (0=no, 1=yes) to five questions on asthma-like 
symptoms in the past 12 months (short of breath while wheezing, woken up with chest tightness, attack of shortness of breath at rest, attack of shortness of breath after 
exercise, woken up by attack of shortness of breath). Positive if yes to ≥2 questions 
WRON symptoms: work related nasal-ocular symptoms; WRC symptoms: work related chest symptoms 
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Table 3.11b: Predictors of spirometry-based airway obstruction diagnoses (unadjusted regression analysis) related to Exposures  
    FEV1<LLN  FEV1/FVC<LLN  FEV1<80%‡  FEV1/FVC<70%‡  Moderate/Severe 
                Obstruction 
Predictors   n=258  n=80   n=35   n=51   n=21   n=11 
Nicotine Exposure       
Previous GTS episode      0.93 (0.53-1.62) 0.97 (0.46-2.05)  0.58 (0.29-1.15)  0.93 (0.36-2.39)  0.69 (0.18-2.67) 
GTS episode in past year    0.87 (0.47-1.60)   1.19 (0.53-2.63)  0.65 (0.30-1.40)  1.51 (0.58-3.92)  1.10 (0.28-4.26) 
Activities related to GTS  
- Sowing      0.47 (0.17-1.30) 0.48 (0.11-2.12)  0.48 (0.14-165)  0.41 (0.52-3.15)  0.85 (0.10-6.91) 
- Transplanting      0.50 (0.16-1.53) 0.30 (0.04-2.30)  0.40 (0.09-1.79)  0.54 (0.07-4.26)  1.14 (0.14-9.32)  
- Harvesting     0.92 (0.45-1.87) 0.59 (0.20-1.77)  0.59 (0.24-1.49)  0.80 (0.22-2.83)  0.47 (0.06-3.80)     
- Curing       1.35 (0.59-3.10) 1.12 (0.36-3.46)  0.91 (0.33-2.54)  0.89 (0.20-4.06)  0.85 (0.10-6.91)  
- Other       1.06 (0.46-2.46) 2.40 (0.94-6.17)  0.65 (0.21-1.96)  2.09 (0.65-6.72)  0.81 (0.10-6.61)    
Pesticide Exposure  
Pesticides application       0.77 (0.45-1.30) 0.82 (0.40-1.66)  1.05 (0.57-1.96)  0.70 (0.29-1.71)   0.65 (0.19-2.18) 
Duration of exposure(Hrs/day)(144) 1.74 (0.72-4.21) 3.97 (1.38-11.40)* 1.98 (0.80-4.86)  3.89 (1.33-11.36)* 5.12 (1.53-17.16)** 
Work near pesticide sprayers     0.79 (0.44-1.41) 0.96 (0.44-2.12)  1.52 (0.73-3.16)  0.96 (0.36-2.59)  0.66 (0.19-2.34) 
Exposure during spraying    1.14 (0.56-2.30) 0.84 (0.31-2.30)  0.95 (0.41-2.19)  0.85 (0.24-3.01)  1.15 (0.24-5.52) 
Pesticide drift         1.54 (0.60-3.92) 1.67 (0.52-5.32)  0.70 (0.20-2.48)  2.16 (0.58-8.06)  2.83 (0.57-14.08) 
Field re-entry after spraying    0.96 (0.47-1.97) 0.72 (0.29-1.78)  1.02 (0.44-2.36)  0.57 (0.20-1.66)  0.84 (0.18-4.06) 
Home use of pesticides          0.79 (0.47-1.35) 0.42 (0.20-0.88)* 0.92 (0.50-1.69)  0.52 (0.21-1.31)  0.50 (0.14-1.74) 
Each entry represent a separate univariate regression between each predictor and each outcome 
*= p≤0.05; **=p≤0.01; ***=p≤0.001;  FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; LLN: Lower limit of normal;  
‡NHANES: National Health And Nutrition Examination Survey III reference values  
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3.12 Biomass exposure as a predictor of respiratory outcomes 
 
The association between biomass exposure and work- related symptoms, asthma 
and COPD symptoms, as well as lung function is outlined in table 3.12a. The logistic 
regression models (unadjusted) showed an increased significant association 
between cooking tasks using biomass fuel with work related nasal-ocular symptoms 
(OR 2.80, CI 1.14-6.88, p≤0.05) and a protective effect with WRCS (OR 0.44, CI 
0.22-0.80, P<0.01).  
Logistic regression models of lung function indices indicated an increased 
association between biomass exposure at work and airflow limitation as reflected in  
FEV1<80% of predicted  (OR 2.20, CI 1.08-4.46, p<0.05).  
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Table 3.12a: Predictors of symptom-based asthma and COPD diagnoses (unadjusted regression analysis) related to Biomass 
Exposure 
_________________________________________________________________________________________________________________ 
     Asthma score≥2 Current Asthma COPD Symptoms   Work related nasal Work related    
ocular symptoms     chest symptoms 
Predictors  n=279  n=65   n=55   n=48   n=57   n=80 
Biomass Fuel                
Exposure to biomass fuel       0.79 (0.36-1.74)  1.31 (0.52-3.32)  1.38 (0.51-3.75)  3.26 (0.96-11.01) 0.62 (0.30-1.27)  
Biomass fuel source  
-Home     0.90 (0.51-1.59)  1.31 (0.72 – 2.37) 1.09 (0.58-2.05)  1.01 (0.56-1.82)  1.64 (0.85-3.14)  
- Work    1.27 (0.63-2.59)  0.78 (0.34 – 1.78) 1.56 (0.73-3.33 ) 0.88 (0.40-1.94)  0.77 (0.45-1.32)  
Tasks associated with exposure 
-cooking   0.59 (0.31-1.11)  1.15 (0.55-2.39)  1.49 (0.66-3.78)  2.80 (1.14-6.88)* 0.44 (0.22-0.80)**  
-curing tobacco   0.98 (0.56-1.72 ) 0.84 (0.46-1.53)  1.02 (0.54-1.91)  1.46 (0.82-2.62)  0.95 (0.56-1.61)  
-smoking tobacco  0.65 (0.14-3.03)  0.81 (0.17-3.80)  0.96 (0.23-4.53)  1.31 (0.34-5.02)  1.26 (0.37-4.30)  
Duration of exposure 
Hours per day (n=241)  0.90 (0.81-1.01)  0.83 (0.72-0.95)  1.05 (0.95-1.16)  0.92 (0.83-1.03)  0.93 (0.84-1.02)  
Each entry represent a separate univariate regression between each predictor and each outcome 
*= p≤0.05; **=p≤0.01; ***=p≤0.001;  
ECRHS Definition of asthma:   
Asthma Score category*Asthma symptom score: An asthma symptom score was computed based on the sum of answers (0=no, 1=yes) to five questions on asthma-like 
symptoms in the past 12 months (short of breath while wheezing, woken up with chest tightness, attack of shortness of breath at rest, attack of shortness of breath after 
exercise, woken up by attack of shortness of breath). Positive if yes to ≥2 questions 
WRON symptoms: work related nasal-ocular symptoms; WRC symptoms: work related chest symptoms  
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Table 3.12b: Predictors of spirometry-based airway obstruction diagnoses (unadjusted regression analysis) related to biomass 
exposures  
     FEV1<LLN  FEV1/FVC<LLN  FEV1<80%‡  FEV1/FVC<70%‡  Moderate/Severe 
                Obstruction 
Predictors  n= 258  n=80   n=35   n=51   n=21   n=11 
Biomass Fuel                
Exposure to biomass fuel 0.84 (0.38-1.83)  0.64 (0.24-1.68)  1.08 (0.42-2.77)  0.57 (0.18-1.81)  1.44 (0.18-11.60) 
Biomass fuel source    
-Home     0.92 (0.54-1.57)  0.93 (0.45-1.93)  0.65 (0.34-1.24)  0.86 (0.34-2.14)  0.80 (0.23-2.80) 
- Work    1.43 (0.74-2.76)  1.63 (0.71-3.76)  2.20 (1.08-4.46)* 1.41 (0.49-4.06)  2.64 (0.74-9.40) 
Tasks associated with exposure  
-cooking   1.04 (0.55-1.98)  0.47 (0.22-1.02)  1.17 (0.55-2.52)  0.41 (0.16-1.05)  0.47 (0.13-1.66)  
-curing tobacco   1.03 (0.60-1.74)  0.81 (0.39-1.66)  1.52 (0.82-2.81)  0.93 (0.38-2.28)  1.52 (0.45-5.11) 
-smoking tobacco  1.12 (0.33-3.83)  Uncalculable  1.38 (0.36-5.27)  Uncalculable  Uncalculable 
Duration of exposure 
- Hours per day (n=225)  1.03 (0.94-1.12)  1.07 (0.95-1.20)  1.10 (1.00-1.21)  1.10 (0.96-1.27)  1.10 (0.92-1.31) 
Each entry represent a separate univariate regression between each predictor and each outcome 
*= p≤0.05; **=p≤0.01; ***=p≤0.001;  
FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; LLN: Lower limit of normal;  
‡NHANES: National Health And Nutrition Examination Survey III reference values 
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3.13 Multivariate analysis of predictors of symptom-based definitions of 
asthma and COPD 
 
A multivariate model of respiratory symptoms adjusted for age, gender, smoking 
status, and childhood respiratory infections is shown in table 3.13a below. Proxies 
for nicotine exposure, were used i.e. previous GTS episodes. Two activities (sowing 
and transplanting) associated with GTS episode showed a significant association 
with all symptom-based respiratory outcomes (OR 1.78-7.26, p<0.05 to p<0.001). 
Harvesting was significantly associated with increased odds of all symptom-based 
outcomes (OR 1.93-8.81, p<0.05 to p<0.001) except for current asthma. Curing was 
associated with current asthma (OR 2.40, CI 1.01-5.71, p<0.05) and work-related 
nasal-ocular symptoms (OR 22.45, CI 8.74-57.68, p<0.001).  
 
Pesticide application showed an increased association with all symptom-based 
respiratory outcomes (OR 1.96-2.62, p>0.01 to p<0.05) except WRCS. Exposure 
during spraying was significantly associated with increased odds of current asthma 
(OR 2.57, CI 1.22-5.40, p<0.05), asthma score (OR 2.09, CI 1.01-4.31, p<0.05), 
WRONS (OR 2.43, CI 1.17-5.04, p<0.05). Pesticide drift was significantly associated 
with increased odds of current asthma  (OR 2.62, CI 1.01-6.86, p<0.05). Re-entry of 
fields after spraying showed an increased significant association with COPD 
symptoms (OR 5.22, CI 1.20-22.75, p<0.05) and protective against ocular nasal 
symptoms (OR 0.45, CI 0.22-0.92, p<0.05) while number of hours of exposure to 
pesticides showed an increased significant association with WRONS (OR 9.50, CI 
2.97-30.34, p<0.001). 
 
Multivariate model for spirometry-based outcomes after adjusting for age, gender, 
smoking, and childhood infections is shown in Table 3.13b. all proxies for nicotine 
exposure did not show any significant associations with the outcomes. Most proxies 
for pesticide exposure did not show any significant association with respiratory 
outcomes except for duration of pesticide exposure which showed increased 
significant association with FEV1/FVC<LLN (OR 5.11, CI 1.57-16.66, p<0.01), 
FEV1/FVC<70% (OR 4.58, CI 1.17-17.98, p<0.05), and moderate to severe airway 
obstruction (OR 13.25, CI 1.69-103.93, p<0.05).  
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Table 3.13a: Multivariate analysis of predictors of symptom-based asthma and COPD diagnoses†  
 
     Asthma score≥2 Current Asthma  COPD Symptoms WR Nasal-ocular  WR chest   
          symptoms  symptoms 
     n=65   n=55   n=48   n=57   n=80 
Nicotine Exposure (n=279)      OR (95% CI) 
 
Previous GTS episode       2.68 (1.48-4.83)** 2.89 (1.55-5.39)**    2.19 (1.12-4.26)* 5.94 (3.10-11.40)*** 3.64 (2.08-6.37)***  
GTS episode in past year   3.28 (1.76-6.13)*** 3.58 (1.87-6.85)***    3.03 (1.49-6.19)** 9.14 (4.51-18.51)*** 3.02 (1.68-5.45)***  
Activities related to GTS  
- Sowing      3.78 (1.62-8.85)** 4.93 (2.10-11.55)***   7.26 (2.86-18.41)*** 5.74 (2.43-13.56)*** 2.49 (1.09-5.70)*  
- Transplanting      3.80 (1.52-9.45)** 2.65 (1.04-6.76)*   5.43 (2.08-14.21)** 6.18 (2.49-15.35)*** 2.23 (0.91-5.50)   
- Harvesting     1.93 (0.96-3.87) 2.01 (0.98-4.13)   2.40 (1.12-5.15)* 8.81 (4.33-17.91)*** 2.65 (1.37-5.11)**  
- Curing       2.11 (0.91-4.88) 2.40 (1.01-5.71)*   2.09 (0.81-5.40)  22.45 (8.74-57.68)*** 1.78 (0.79-4.02)         
Other      3.84 (1.68-8.75)** 2.92 (1.24-6.72)*   1.34 (0.49-3.66)  0.70 (0.24-2.00)  4.07 (1.81-9.17)**  
Pesticide Exposure (n=279) 
 
Pesticide application     2.35 (1.24-4.44)* 2.05 (1.05-3.99)* 2.62 (1.25-5.51)* 1.96 (1.03-3.71)* 1.50 (0.85-2.62)   
Exposure during spraying   2.09 (1.01-4.31)* 2.57 (1.22-5.40)* 1.05 (0.45-2.49)  2.43 (1.17-5.04)* 1.54 (0.75-3.13)   
Pesticide drift      2.43 (0.96-6.17)  2.62 (1.00-6.86)* 1.42 (0.47-4.28)  3.00 (1.18-7.62)* 1.81 (0.72-4.58)   
Field re-entry  after spraying 2.13 (0.85-5.35)  1.31 (0.55-3.16)  5.22 (1.20-22.75)* 0.45 (0.22-0.92)*    1.09 (0.53-2.27)   
Duration of exposure (Hrs/day) 1.06 (0.75-1.49)  0.92 (0.54-1.58)  1.20 (0.86-1.68)  9.50 (2.97-30.34)*** 1.02 (0.72-1.45)   
*= p≤0.05; **=p≤0.01; ***=p≤0.001;  
Current asthma: defined as either having shortness of breath in the past 12 months or an asthma attack in the past 12 months or current use of asthma medication  
Asthma Score category*Asthma symptom score: An asthma symptom score was computed based on the sum of answers (0=no, 1=yes) to five questions on asthma-like 
symptoms in the past 12 months (short of breath while wheezing, woken up with chest tightness, attack of shortness of breath at rest, attack of shortness of breath after 
exercise, woken up by attack of shortness of breath). Positive if yes to ≥2 questions 
WRON symptoms: work related nasal-ocular symptoms; WRC symptoms: work related chest symptoms  
† Each estimate based on individual regression models that have been adjusted for age, gender smoking and childhood chest infections  
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Table 3.13b: Multivariate analysis of predictors of spirometry-based airway obstruction diagnoses† 
     FEV1<LLN  FEV1/FVC<LLN  FEV1<80%‡  FEV1/FVC<70%‡  Moderate/Severe 
                Obstruction 
Predictors  n= 258  n=80   n=35   n=51   n=21   n=11 
Nicotine Exposure (n=279)      OR (95% CI) 
 
Previous GTS episode    0.95 (0.54-1.68)  0.95 (0.44-2.04)  0.55 (0.27-1.12)  0.87 (0.32-2.33)  0.58 (0.14-2.37) 
GTS episode in past year 0.89 (0.47-1.67)  1.20 (0.53-2.72)  0.64 (0.29-1.39)  1.41 (0.52-3.88)  0.95 (0.22-4.00) 
Activities related to GTS  
- Sowing   0.45 (0.16-1.27)  0.48 (0.11-2.17)  0.43 (0.12-1.54)  0.42 (0.05-3.38)  0.81 (0.09-7.15) 
- Transplanting   0.45 (0.14-1.42)  0.28 (0.04-2.22)  0.34 (0.07-1.55)  0.52 (0.06-4.32)  0.96 (0.11-8.51) 
- Harvesting  0.89 (0.43-1.83)  0.59 (0.20-1.79)  0.58 (0.23-1.49)  0.80 (0.22-2.93)  0.49 (0.06-4.02) 
- Curing    1.34 (0.58-3.13)  1.23 (0.39-3.82)  1.00 (0.34-2.83)  0.87 (0.18-4.13)  0.91 (0.11-7.76) 
- Other    1.19 (0.50-2.83)  2.24 (0.85-5.91)  0.61 (0.19-1.90)  1.66 (0.48-5.74)  0.49 (0.05-4.56) 
Pesticides 
Pesticide application     0.74 (0.43-1.28)  0.79 (0.38-1.66)  0.92 (0.48-1.75)  0.77 (0.30-1.97)  0.56 (0.15-2.06)   
Exposure during spraying   0.96 (0.46-2.01)  0.81 (0.28-2.34)  0.72 (0.29-1.76)  1.05 (0.28-4.00)  1.12 (0.21-6.08)   
Pesticide drift      1.39 (0.54-3.60)  1.91 (0.58-6.23)  0.69 (0.19-2.52)  2.84 (0.71-11.38) 4.01 (0.74-21.86) 
Field re-entry  after spraying 0.91 (0.43-1.89)  0.71 (0.28-1.79)  0.94 (0.40-2.21)  0.65 (0.21-1.97)    0.91 (0.18-4.60)   
Duration of exposure (Hrs/day) 1.97 (0.80-4.84)  5.11 (1.57-16.66)** 2.41 (0.95-6.11)  4.58 (1.17-17.98)* 13.25 (1.69-103.93)* 
*= p≤0.05; **=p≤0.01; ***=p≤0.001;  
FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; LLN: Lower limit of normal;  
‡NHANES: National Health And Nutrition Examination Survey III reference values 




CHAPTER 4: DISCUSSION 
 
This study reveals that tobacco farmers in this setting are predominantly young 
adults most of whom are educated to the primary level with a mean employment 
duration of 7.3 years. These farmers are more exposed to risky social behaviors 
such as current alcohol consumption (42%) and current smoking (20%) compared to 
the national average of 17.3% and 11% respectively80. A study among urban 
dwellers in Malawi revealed a lower prevalence of ever smoking of 10% compared to 
27% in our study6. One Brazilian study among tobacco farmers reported a 
comparable prevalence of smokers among tobacco farmers of 17% though another 
Brazilian study reported a high prevalence of 33%68,13. Lopes investigated factors 
associated with heavy drinking among 2469 randomly selected tobacco farmers81. 
Their findings showed that high risk and heavy drinking were associated with male 
gender, having no partner, being an employee, frequency of pesticide use in both 
males and females. Among males, other risk factors for drinking were smoking (PR 
1.46, CI 1.22-1.73), higher working hours (>12) (PR 1.81, CI 1.19-2.74), crop loss 
(PR 1.24, CI 1.06-1.45), having a loan (PR 1.62, CI 1.24-2.13). While the factors 
above could be relevant to this study, a higher prevalence of smoking and alcohol in 
this rural population may signify a lack of health information related to healthier 
lifestyles among these rural farmers compared other parts of the country where 
health information is readily available through various media portals. The experience 
showed that the farms were located in very remote and hard to reach areas where it 
was difficult to access phone networks. It was also noted that these farms did not 
have any particular workplace health programs or policies in place.  
 
There was an observation of a very high prevalence of HIV infection (16%) in this 
particular population which is double the national average of 8%.  The Demographic 
and Health survey 2015-2016 reported that HIV prevalence in Malawi is high in 
urban settings with an average of 14.6% compared to rural areas at 7.4%82. Another 
study observing the trends in HIV prevalence in Northern Malawi demonstrated a 
higher HIV prevalence among women closer to the roads than those in remote areas 
among those tested at antenatal clinics83. There was a higher HIV prevalence in our 




daily earning capacity among the seasonal workers and larger labor force in these 
estates put these workers at a particular social risk in their environment similar to 
that observed in higher income populations.  
 
Previous chest infections in childhood were significantly associated with chest 
diagnoses such as asthma, COPD, and work- related chest symptoms but not ocular 
nasal symptoms. History of chest infection is a documented risk factor for obstructive 
lung diseases84. Although the types of past infections were not documented in this 
study, in general terms, infections are associated with activation of both immune-
mediated and irritant mechanisms likely to affect those affected making their airways 
hyper-responsive to other stimuli85. 
 
This study demonstrates a higher prevalence of obstructive lung diseases (asthma 
and chronic bronchitis) among tobacco farmers in Malawi compared to other studies. 
The findings in other studies measuring individual respiratory symptoms such as 
wheezes among tobacco farmers found lower prevalence of 11%13 and 16%86. Other 
symptoms in this study, such as shortness of breath (30%), were comparable to 
findings by Gosh and others (20%)87 and higher than a study by Van Minh (24.3%)37. 
The strength of this study is the use of the standardized symptoms definitions of 
asthma and chronic bronchitis which other studies among tobacco farmers did not 
demonstrate. This enables us to establish that obstructive lung diseases are more 
prevalent among tobacco farm workers than previously thought. 
 
One unique feature of this particular study is the characteristic higher prevalence of 
work-related chest symptoms compared to upper airway symptoms. Usually, 
airborne workplace respiratory hazards such as dust reach the upper airways first in 
higher concentrations. Due to immune mechanisms in the respiratory tract the 
concentration is gradually reduced down the tract as more particles get trapped 
before they descend to the lower respiratory tract. Thus, one would expect more and 
early symptoms to be manifested on the upper side of the respiratory tract than 
otherwise. However, this is not the pattern of respiratory symptoms demonstrated in 
this study. There could be possible explanations for this particular pattern. Firstly, it 
could be that the hazard responsible for these respiratory effects reaches the 




possible route could be dermal, in case of both nicotine and pesticides. This makes it 
possible for the hazard to evade the natural airway protective mechanism and reach 
any part of the body including the lungs in somewhat different concentrations and 
exert its effects there. This is likely to happen in this population especially 
considering the low prevalence of those using personal protective equipment. 
Another explanation could be that the characteristics of the upper airways make it 
more resilient to this particular hazard encountered by tobacco farmers than does 
the lower respiratory tract. Thirdly, a hazard with very small particle sizes in the 
respirable ranges or those in gaseous forms are likely to reach the lower parts of the 
respiratory system in rather higher concentrations. In the context of the delicate 
nature of that part of the respiratory tract an exposed individual may experience the 
adverse effects quicker than otherwise. 
 
There was a higher prevalence (20%) of spirometry- based airway obstruction 
among rural based tobacco farmers demonstrated in this study compared to the 
urban dwellers (3.6%) using similar reference values (NHANES III)6. Moderate to 
severe obstruction (sub-optimal FEV1 and FEV1/FVC) was higher among the 
tobacco farmers than the urban dwellers. This finding points to the significant role 
that occupational exposures in the tobacco farms may have on respiratory health 
outcomes. The association between tobacco farming and airway limitations observed 
through spirometry has been previously described88,87. While there was comparable 
prevalence of other important exposures such as using biomass fuel between the 
two populations the notable exposure differences were occupation and high smoking 
prevalence. Urban dwellers do not usually engage in commercial farm activities 
since most farms are located in the remote country sides. The tobacco farmers also 
demonstrated a higher prevalence of obstruction when calculations were based on 
the GLI reference equation FEV1<Lower Limit of Normal (LLN), 31%. Use of 
spirometry equations in interpreting spirometry results should seriously consider the 
racial or ethnic differences. While the NHANES reference equations applied in this 
study are derived from multiple races which include African Americans the GLI 
equations were mainly based on the European population leading to overestimation 
of abnormalities89,90. Despite the limitations, NHANES references were used to 
provide a basis of comparison with other studies in Malawi which were conducted 




our sample on which to base our lower limit values. The discrepancies observed with 
usage of GLI in Africa has prompted recommendations to incorporate African data in 
these equations. 
 
In this study, GTS was used as proxy measure for nicotine exposure. GTS was 
defined as having any of the four symptoms (headache, dizziness, nausea, and 
vomiting) and was noted in 26% of the participants in the previous year. This was 
relatively higher than one of the Brazilian studies which needed at least 2 symptoms 
to define GTS in which the prevalence was 11%13. When the definition was modified 
to align with the Brazilian study, the prevalence dropped to 14% which is still higher 
but comparable. Another Brazilian study documented a much higher prevalence of 
GTS reaching up to 67% of the participants despite being a smaller sample size of 
100 conveniently selected participants subjecting it to selection bias68. Other studies 
have reported rather higher prevalence based on more inclusive definitions of the 
condition such as gastrointestinal and respiratory symptoms87. 
 
Farmers reported an average of three GTS episodes in a year and reported most of 
the symptoms appearing on the same day of exposure. This is comparable to the 
study by Fiori which reported a majority have 1 to 5 GTS episodes  within a year13. 
Main tasks associated with GTS symptoms were harvesting followed by curing. 
Harvesting tobacco has been documented as the commonest source of nicotine 
exposure through the dermal route among tobacco farmers. In this setting tobacco 
harvesters perform their tasks without protective equipment making them susceptible 
to nicotine absorption through the skin. In Malawi, tobacco is harvested in December 
and January and usually in the morning hours. These months are the wettest months 
in the calendar in terms of rain fall. Harvesting in the morning, subjects the farmers 
to other forms of moist conditions such as morning dew. All these conditions promote 
nicotine absorption and subsequent toxicity predisposing to GTS. 
 
Flue-curing involved collecting green tobacco leaves soon after harvesting and 
hanging them in curing barns by tying them. While harvesting was done by a majority 
of the workers, curing was done by a selected few who were trained in the 
processes. Since these estates produce flue-cured tobacco, it meant that these 




them to the barns. In the early stages of harvesting the same workers were also 
involved in harvesting. Even though harvesting involved larger numbers of workers in 
general it could be postulated that individuals involved in curing in these estates 
were likely to succumb to the dose-dependent effects of nicotine exposure. A 
comparable number of participants reported tasks such as sowing as being 
responsible for their symptoms. While this relationship is not documented, sowing is 
generally associated with rigorous use of pesticides and it is the peak stage of 
pesticides application during tobacco cultivation. It is possible that the symptoms 
reported could be as a result of pesticide poisoning as reported in other studies91,92. 
 
GTS was significantly associated with an increase of all symptom based respiratory 
outcomes both independently and after adjusting for age, sex, smoking, and 
childhood infections. Fiori et al demonstrated a relationship between number of GTS 
episodes and occurrence of wheeze among tobacco farmers13. Although their study 
did not have extensive evaluation of the respiratory symptoms, wheezing was used 
as a proxy for asthma. In this study, GTS was associated with both definitions of 
asthma as well as COPD. This finding adds value to the existing evidence indicating 
that beyond wheezing nicotine exposure is also associated with other types of 
chronic respiratory symptoms signifying chronic bronchitis. Furthermore, the 
symptoms of GTS were associated with both work-related upper and lower 
respiratory symptoms. This might indicate the role of nicotine as an occupational 
hazard in the occurrence of these symptoms. 
 
Following absorption of nicotine including dermal means, it enters into the blood 
stream where only less than 5% is bound to plasm proteins. The rest is extensively 
distributed to body tissues with highest affinity for  the brain, liver, kidney, spleen and 
the lungs22. An in vitro study on human airway cell culture exposure to nicotine 
revealed its effects on the viscosity of airway mucins57. Mucins exposed to nicotine 
were aggregated and less hydrated causing them to be thicker. The investigator 
postulated that this mechanism could explain why smokers usually have thicker 
airway secretions. The high affinity of lung cells to nicotine may lead to a 
considerable exposure of the cells to similar effects in vivo even though this has not 
been documented. In vivo nicotine has been demonstrated to influence the 




bronchoconstriction and excess mucus production58. Studies on respiratory health 
effects of nicotine exposure through tobacco smoke show that nicotine plays a role in 
development of emphysema by decreasing elastin in the alveolar parenchyma and 
increased alveolar volume which leads to development of COPD. Its effects on the 
autonomic nervous system through vagal reflexes have been shown to cause 
bronchoconstriction21.  
 
Three main activities (sowing, transplanting, and harvesting) were significantly 
associated with asthma, COPD, work related upper and lower respiratory symptoms 
in our multivariate analysis. Curing was associated with all respiratory outcomes 
except work related chest symptoms. While transplanting, harvesting and curing are 
involved with touching the fresh tobacco plant or leaves, sowing does not involve 
touching the tobacco plant. However, during sowing farmers are extensively exposed 
to tobacco pesticides used to sterilize the nurseries. The association observed in this 
task with GTS symptoms could be non-specifically linked to chemical exposure. Fiori 
and others found a relationship between lifting tobacco sticks to the curing barns and 
wheezing13. Nevertheless, harvesting and curing which are associated with high 
nicotine exposure have been linked with development of respiratory symptoms in our 
study. 
 
There was a higher prevalence of farmers in this study who reported contact with 
pesticides at work compared to other documented studies among tobacco farmers13, 
with the exception of one other study which documented a much higher proportion 
(97%) of farm workers contacting pesticides68. Of particular interest is the fact that 
only less than half of the farmers who reported to work with pesticides indicated 
pesticides handling as their job title. This signifies a possible danger in pesticide 
exposure to individuals who are not trained to handle pesticides. Another key finding 
was that several pesticides that were reported as being used by participants were 
different from the list of recommended pesticides for use by the Tobacco 
Commission in the country26. For example, some of the pesticides reported in this 
study were banned for use among tobacco farmers based on their updated 
guidelines which considers both resistance as well environmental effects. AChE 
inhibitors (including organophosphates) constituted the commonly used group of 




pesticide exposure including: inadequate use of personal protective equipment by 
sprayers and other farm workers; a very high percentage (83%) reported entering 
fields soon after spraying implying a much greater proportion are exposed to 
pesticides. It was noted that as much as half of the participants used pesticides at 
home for their own gardens and grain storage. The commonest used pesticide at 
participants’ homes were pirimiphos-methyl which is also an AChE inhibitor and have 
similar effects as organophosphates used in the tobacco fields. The proportion of 
farmers using AChE inhibitors at home is twice as much as those using the 
chemicals in the field. This finding demonstrates that workplace data alone may 
underestimate the magnitude of exposure and their health effects among these 
participants.  
 
This study has documented the major groups of pesticides involved in the tobacco 
cultivation process in Malawi and their proportion of use. Of note is that most of the 
listed pesticides have been independently associated with adverse respiratory 
effects among farmers through various mechanisms48. The effect of concurrent use 
of these groups of pesticides on the health outcomes is uncertain. 
 
The study revealed an association between pesticides exposure and asthma 
definitions, chronic bronchitis, as well as work related ocular nasal symptoms but not 
work- related chest symptoms. Wheeze was shown to be associated with exposure 
to pesticides in Agriculture Health Study among commercial pesticide applicators by 
Hoppin39. After adjusting for confounders organophosphates remained significantly 
associated with wheeze (OR 2.72, 95 percent CI: 1.54, 4.81). The fact that AChE 
inhibitors were more prevalent in our study than any other pesticides may explain the 
similar trends in this study. A study in Brazil among agricultural health workers 
showed an increased association between pesticides (generally) and adult onset 
asthma (OR = 1.54, 95% CI: 1.04–2.58)30 while a Canadian study on male farmers 
showed an association between self-reported asthma and carbamate (AChE 
inhibitor) pesticides (OR = 1.8, 95% CI: 1.1–3.1)93.  
 
Several studies have shown the role of pesticide exposure in airway symptoms 
including both atopic and non-atopic asthma. Hoppin demonstrated that several 




with non-atopic asthma39. A study among French farmers found an increased 
association between pesticide exposure and allergic asthma (OR 1.97, CI 1.43–2.73) 
than non-allergic asthma (OR 1.24, CI 0.88–1.76)94. The authors postulated that the 
allergic mechanisms could be through indirect effects of pesticides on the immune 
system such as Th1 and Th2. Both animal and human studies of AChE exposure 
through organophosphates and organochlorides demonstrate Th1 suppression with 
concurrent increase in Th2 suggesting type 1 reactions95. A study by Mwanga 
demonstrated an association between organophosphates and pyrethroids with 
probable allergic asthma (FeNO>50ppb) through Th2 and non-Th2 mechanisms40. 
Another study by Ndlovu exhibited a positive associationbetween AChE suppression 
due to pesticide exposure and possible allergic asthma (FeNO>25ppb)41. In the 
same study several proxies for pesticide exposure were independently associated 
with a higher asthma score. Low AChE (OR 1.93, CI 1.09-3.44), Pesticide drift (OR 
2.03, CI 1.38-2.98), number of pesticides spraying days (OR 1.01, CI 1.00-1.01) 
were significantly associated with increased asthma score. The present study shows 
the significance of duration of exposure as a predictor of dose. The findings showed 
an increased though non-significant relationship between duration of pesticide use 
and asthma score, COPD, and work-related chest symptoms. The isolated stronger 
and significant increased association observed between the duration of exposure 
and ocular nasal symptoms could be due to the acute effects occurring during 
spraying. Duration of exposure to pesticides is documented as an important predictor 
of toxicity28. These relationships reported in the above studies are in agreement with 
the existent associations between pesticide exposure proxies and asthma outcomes 
in our study. 
 
It has been observed in animal studies (guinea pigs) that AChE inhibitor pesticides 
such as organophosphates induce airway hyperactivity at doses lower than those 
that show effects of AChE inhibition96. This has been shown to occur through neural 
and inflammatory pathways. Organophosphates either induce airways hyperactivity 
by potentiating M3 airway smooth muscle receptors or by blocking autoinhibitory M2 
receptors on airway parasympathetic nerves. Low level organophosphates were also 
observed to enhance immune responses to other chemical allergens and to 
exacerbate eosinophilia in allergic airway inflammation. The above mechanism could 





The Agriculture Health Study by Hoppin demonstrated the relationship between 
pesticide application and chronic bronchitis among farmers (OR=1.83, 95% CI= 1.50, 
2.24). This study which followed a cohort of 20,908 pesticide applicators was able to 
establish the role that similar groups of pesticides as the ones applied on tobacco 
have, in the development of chronic bronchitis49. One important finding was that 
AChE inhibitors (organochlorides and organophosphate) were predominantly 
associated with chronic bronchitis symptoms compared to other symptoms. While it 
was feasible to isolate the groups of pesticides in their study the farmers in our study 
had concurrent exposures to multiple pesticides some of which they could not 
remember. The higher odds of bronchitis in our study among pesticides exposed 
farmers suggest the synergistic or additive role of concurrent exposures.   
 
This study showed a significant association between pesticide exposure and work- 
related upper airway symptoms. There was a positive but non-significant association 
between all proxies of pesticide exposure and work- related chest symptoms. 
Several studies have also reported similar associations while demonstrating the 
significant role that organophosphates had on those symptoms97.  
 
Furthermore, there was an association between duration of pesticide application in 
hours per day with some spirometry indices indicating airway limitation. Moderate to 
severe obstruction was strongest compared to isolated lower FEV1/FVC ratio. This is 
consistent with findings from several other studies which demonstrated a relationship 
between pesticide exposure and abnormal lung functions42,97. In these studies, 
AChE inhibitors including organophosphates, organochlorides and carbamates were 
shown to have a significant role in airway limitation.  
 
Our participants reported extensive use of biomass fuel (87%), predominantly 
firewood (86%) almost daily. In the study done in urban Malawi there was a 
comparable proportion of biomass fuel use (85%), however, it was predominantly 
charcoal. Nearly half (44%) of the respondents indicated workplace exposure to 
biomass fuel and curing was reported as the source of this exposure. As much as 
78% reported biomass fuel exposure through cooking (mainly at home). There were 




use firewood. This might entail similar exposure characteristics between home users 
of firewood and those involved in curing at the workplace though dose of exposure 
might be different for those exposed in both home and workplace. 
 
Biomass fuel use showed an increased significant association with work related 
nasal-ocular symptoms and protective against work related chest symptoms but did 
not demonstrate a substantive role in causing airway obstruction. The increased 
association with nasal-ocular symptoms might explain the acute effects of biomass 
fuel exposure which eventually leads to those individuals ceasing those tasks with 
time thereby demonstrating a protective effect for  more chronic symptoms like chest 
symptoms. Biomass exposure at work showed an increased significant association 
with FEV1<80% demonstrating a role in airflow limitation. This is contrary to a study 
in Malawi conducted in urban dwellers where biomass use at home did not show any 
significant association in causing airway obstruction6. Indoor air pollution through 
biomass fuel is a well-known cause of COPD despite our findings. In this study, it is 
evident that biomass fuel use was very common and involved nearly all participants 
making it unlikely to have power to show differential effects statistically among the 
participants who reported to have symptoms. 
 
The findings of this study demonstrate the role of gender in occupational health. 
Males were employed for a relatively longer period than females. This might be due 
to the social set up in gender roles in the homes making females unable to sustain 
employment longer than males where males are considered bread winners and 
females being there to care for the homes98. Studies show that level of schooling is 
associated with personal health99. The fact that women had a relatively lower 
education level could easily make them more vulnerable to health risks in the 
workplace. Additionally, education level determines the ability to read and 
understand instructions including precautions against workplace hazards. Some 
respiratory outcomes showed differing pictures of association with gender. Males 
reported a higher prevalence of childhood asthma compared to females. Females 
reported a higher rate of eye symptoms and more women had an FEV1 less than  the 
lower limit of normal (LLN) than men. No other outcomes have shown a significant 
increased association with  gender. Considering the relatively shorter period of 




might explain the role of some gender specific vulnerabilities that disproportionately 
put females at an increased risk of respiratory outcomes in these occupational 
settings. 
 
This study shows an increased risk of obstructive airway conditions among tobacco 
farmers in Malawi exposed to pesticides and nicotine. This study has employed the 
use of standardized outcome definitions and spirometry measurements to determine 
outcomes in this group of agricultural workers, enhancing the robustness of 
estimates generated and adding to an understanding of risk to respiratory health 
faced by tobacco farmers. 
 
This study had several limitations. Firstly, the study design, being cross-sectional 
could not establish the causal relationship between the exposures and the 
outcomes. Secondly, the sample population being from one district and among flue 
cured tobacco farmers limits the generalizability of this study to the whole tobacco 
industry in Malawi which is dominated by burley tobacco. Thirdly, the convenient 
sampling method could subject it to selection bias with possibility of a healthy worker 
effect on our findings making us miss more serious cases of poor respiratory health. 
This would have the effect of underestimating the risk and attenuating the positive 
associations found.  Fourthly, the use of questionnaire- based proxies of exposures 
and outcomes were subject to recall bias potentially leading to differential recall 
among the symptomatic cases compared to, asymptomatic individuals who could 
have significant levels of exposure. 
 
In conclusion, this study has shown that tobacco farmers in Malawi have a higher 
prevalence of asthma and chronic bronchitis compared to farmers in other settings 
and the general population. Additionally, nicotine and pesticide exposures are key 
factors associated with obstructive lung diseases including work related upper and 
lower airway symptoms among the farmers with nicotine showing the strongest 








This study which was aimed at investigating the risk factors associated with 
obstructive airway diseases among Malawian tobacco farmers has concluded that 
these farmers are at an increased risk of developing obstructive lung disease which 
is strongly associated with their exposure to nicotine and pesticides in the workplace. 
 
Several recommendations are proposed to safeguard the health and safety of these 
tobacco farm workers against these commonly encountered hazards in the 
workplace.  
 
Firstly, necessary legislation needs to be enacted or reviewed to include seasonal 
workers in tobacco estates as employees to be protected by the Occupational 
Safety, Health and Welfare Act (OSHWA) of 1997100. The current legislation does 
not recognize these estates as being workplaces governed by the particular act. 
According to the Malawi Occupational Health Profile of 2009101 the informal sector 
constitutes 89% of the labor force and seasonal workers in tobacco estates fall under 
that majority category of workers who are not properly protected by the law. 
Legislation is a paramount driver of occupational health practice globally and any 
efforts to implement occupational health and safety would prove futile in the absence 
of proper legislation. The effectiveness of the existing legislation should be 
measured in its ability to promote the common good of the citizenry. In this instance 
having the legislation in place which cannot protect nearly 90% of the potential 
beneficiaries is a serious concern. While the OSHWA 1997 itself is lacking, the other 
necessary act is the Workers Compensation Act (WCA)102. This act ensures justice 
for those that become victims under the provisions of the OSHWA. It is noted that 
the current WCA does not schedule such common occupational respiratory diseases 
as Asthma, Rhinitis, COPD. This observation means that workers suffering from 
these conditions are likely to go unreported and not compensated eventually for their 
disability. It is also recommended that the WCA be reviewed to make it cover the 
Malawian workforce adequately. 
 
Secondly, during this study, it was noted that tobacco estates do not follow strict 




recommended list of pesticides as published by the Tobacco Commission26; 
applicants do not use PPE adequately; other workers are not adequately protected 
from exposure during spraying times. The tobacco cultivation sector needs to 
enforce strict occupational hygiene principles for handling any hazardous substances 
including pesticides. There is a need for the proper practice of hierarchy of controls 
when dealing with the common hazards in these farms.  
 
There is also a need to adopt an understanding that nicotine is a chemical hazard 
associated with serious reversible and non-reversible health effects and, therefore, 
exposure to it needs to be regulated with possible use of PPE for all workers 
handling tobacco as is the practice in other countries. Training is also necessary for 
all the workers to be conversant with some safety standards of practice in handling 
these workplace hazards. 
 
Thirdly, due to the nature of these health effects it is necessary to institute a medical 
surveillance program for all tobacco workers in their workplaces. This would be the 
responsibility of the ministry of health, ministry of labor along with the Tobacco 
Commission. This is justified by the levels of toxicity of the chemicals that farmers 
are exposed to and the high prevalence of undetected health effects among them. 
Medical surveillance program will be an important tool for early detection of these 
health effects in this vulnerable population. Some of the important actions taken 
following such exercise would be: reducing exposure by switching or withdrawing 
affected employees from insulting hazards; treating the affected employees; 
rehabilitation; and compensation. 
 
Fourthly, the regulatory authority for tobacco production, the Tobacco Commission, 
needs to consider health and safety compliance as one mandatory requirement for 
licensing tobacco producers in the country. Such a recommendation necessitates 
frequent inspections and audits among the farms by the authority to ensure 
compliance with the set standards. Heavy penalties need to be attached to 






Another issue to be considered is the implementation of workplace HIV/AIDS 
policy103 in these workplaces. Considering the number of employees and the HIV 
burden at such workplaces deliberate efforts need to be put in place through 
employers and other partners to include these workers in HIV/AIDS information, 
education and communication. From the findings of this study it was evident that the 
prevalence was more than double compared to rural average in these workplaces 
signifying a very high concentration of the people living with HIV. These people need 
different kinds of support services for them to live a healthy and productive life. The 
HIV workplace policy of Malawi encourages workplace to design work in such a way 
that does not compromise the health and wellbeing of those infected. Other 
initiatives include special support for the employees who voluntarily disclose their 
status and zero discrimination at workplace on the basis of HIV status. 
 
There are some recommendations for further research which would establish more 
evidence regarding health effects of tobacco cultivation. Some key areas that did not 
form the basis of data collected in this study and need further consideration include 
the following: 
• Quantitative analysis of the particular exposures based on environmental and 
hygiene surveys; 
• Pathophysiological mechanisms of nicotine and pesticides in causing 
obstructive diseases among tobacco farmers; 
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APPENDIX 3: INFORMED CONSENT 
UCT STUDY OF OBSTRUCTIVE LUNG DISEASES AMONG TOBACCO 
FARMERS IN MALAWI – 2017 
ENGLISH CONSENT FORM 
1. Title of research project
A study of obstructive lung diseases among tobacco farmers in Malawi
2. Purpose of the research
This research will form a basis for master’s degree program and will also help
to inform us about the extent of chronic lung diseases in Malawian tobacco
farmers and possible contributors to such diseases. This information may help
us to come up with proper interventions aimed at reducing the prevalence of
such diseases.
3. Description of the research project
If you agree to participate you will be asked to complete the following tests
during working time:
a) Complete a questionnaire
A member of our study team will interview you in privacy to complete the
questionnaire. You will be asked questions about respiratory diseases
symptoms, current and previous employment history, risk factors related to
potential harmful exposures (questions will cover environmental, occupational
and personal factors).
b) Examination
A member of our study team will examine your body to measure blood
pressure, weight, height, temperature as part of the process of gathering
baseline health information
c) Spirometry Test and FeNO test
The team will examine the functioning of your lungs by conducting a
spirometry test that requires you to forcefully exhale and blow through a
portable machine held in your hands for a few seconds. They will also assess




A urine test will be done to measure the presence of nicotine in your urine.  A 
member of the study team will require a 50ml urine sample from you for that 
purpose. The urine samples will be stored and may be tested to look for the 
presence of other biological substances (biomarkers) at a later stage. 
e) Blood test
Venous blood will be collected from you by trained personnel into two tubes
and will be sent to a laboratory to check for an immune response to allergens
as well as pesticides exposure. The blood samples will be stored and may be
tested to look for the presence of other biological substances (biomarkers) at
a later stage.
f) HIV test
You will be asked to provide documented results for your recent HIV test. If
these are not available you will be asked to provide blood for an HIV test. This
will be obtained from a fingerprick sample taken by a trained personnel and
member of the research team. You will be asked whether you wish to be
given your result. If you do wish to have your result, you will be referred to an
independent agency for Voluntary, counselling and testing. This will include
counseling and appropriate referral for further care depending on your test
result. Your test result will be kept confidential and disclosed only to you. You
have the right to refuse the HIV test but still enroll into the study.
4. Confidentiality of information collected
Your name will not appear in any reports on this study. The records of
spirometry, FeNO test, blood tests, and urine tests will be kept completely
confidential and will be seen only by members of the study team.
5. Risks and discomforts of the research
a) From the blood tests.
You will feel a single needle stick when the blood is taken. Sometimes a
small bruise may occur from the needle stick, but this is minor and will heal
quickly.  The total amount of blood taken is quite small and your body will
quickly replace it.
b) From Spirometry and FeNO
You may experience some discomfort due to the requirement to breathe
out forcibly for three occasions otherwise it will be done within your
capacity.
c) From urine test
You will submit this sample from your normal urine stream and we do not
anticipate any discomfort to you during the collection of the urine sample. 
d) From the questionnaire
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    There are no risks associated with the questionnaire and all information will 
be treated as confidential.  
6. Expected benefits to you and to others
You will be given a written copy of all your test results along with an
explanation of what they mean, unless you tell us that you do not wish to
receive this.  You may wish to show these to your doctor if you are having any
problems.  These tests will help determine if you have any obstructive lung
disease. Your participation will help to us understand the spectrum of
respiratory health problems of tobacco farmers and may inform
recommendations for better practices to safeguard health of workers engaged
in tobacco farming.
7. Costs to you resulting from participation in the study
The study is offered at no cost to you.  In the event of an abnormal test result
requiring further investigation or management you will be referred to a facility
for further investigation and care
8. Voluntariness
Your participation in this study is entirely voluntary and you are free to
withdraw at any particular time and you shall not be penalized for doing so.
9. Contact person.
You may contact the following person for answers to further questions about
the research, your rights, or any injury you may feel is related to the study.
University of Cape Town Researchers:
Dr. Yotam Moyo, C/O Johns Hopkins Project, Queen Elizabeth Central
Hospital Campus, P.O. Box 1131, Blantyre. Telephone No. (265) 999 329
438, Mobile No. (265) 888820011
Human Research Ethics Committee, E 53, Room 46, Old Main Building,




UCT- STUDY OF OBSTRUCTIVE LUNG DISEASES AMONG TOBACCO 
FARMERS IN MALAWI – 2017 
 
 
ENGLISH CONSENT FORM  
 
 




10. Consent of the participant 
  
I have read the information given above, or it has been read to me.  I 
understand the meaning of this information, Dr./Mr./Ms. 
________________________________________________________ 
 
has offered to answer any questions concerning the study.  By signing this 
form, I hereby consent to participate in the study.  I also understand that I am 
free to withdraw from the study at any time without penalty. 
 
11. Documentation of the consent 
  
 One copy of this signed document will be kept together with our research 
records for this study. A copy of the information sheet about the study will be given to 











 Interviewer’s name (Print)    Signature 
 
 












UCT OBSTRUCTIVE LUNG DISEASE AMONG MALAWIAN TOBACCO FARMERS - 2017/8 
             
 
ENGLISH QUESTIONNAIRE 
Note: Answer ALL questions.  Insert a cross (X) where appropriate 
             
 Survey Number                  
             
 Employer/Farm name:             
             
 Site or location:              
              
 Districts               
             
 A. DEMOGRAPHIC DATA 
              
 1. Surname                  
              
 2. First name/s                 
             
 3. Address                 
                    
                    
                    
             
 4. Work number              
             
 5. Date of birth:   Day   Month   Year     
              
 6. Gender        Male 1  
          Female 2   
             
 7. Years of schooling      0 1  
         1-4 2   
         5-8 3   
         9-12 4   
90 
>12 5 












10. Farm /estate size Hectares 
11. Amount of tobacco produced per season Kg 
12. Other crops grown on the farm
13. Employment duration (Years)
14. Work schedule/shift
_______________________
__ Day 1 
Night 2 
15 Last work day? Day Month Year 
B. HEALTH PROBLEMS
Wheeze and tightness in the chest 
1 Have you ever had  wheezing or whistling in your Yes 1 
chest in the past? No 0 
If YES, go on to Question 1.1 
If NO, skip to Question 2 
1.1 If yes, when was the first time 
you had these symptoms? Month Year 
1.2 Have you had wheezing or whistling in your chest at Yes 1 
any time in the last 12 months?  No 0 
91 
If YES, go on to Question 1.2.1 
If NO, skip to Question 3 
1.2.1 Have you been short of breath when the wheezing Yes 1 
noise was present? No 0 
1.2.2 Have you had this wheezing or whistling when you Yes 1 
did not have a cold or flu? No 0 
2 Have you been woken up with a feeling of tightness Yes 1 
in your chest at any time in the last 12 months? No 0 
Shortness of breath 
3 Have you had an attack of shortness of breath that  Yes 1 
came on during the daytime when you were at rest No 0 
 at any time in the last 12 months? 
4 Have you had an attack of shortness of breath that Yes 1 
came on following running or exercise at any time No 0 
 in the last 12 months? 
5 Have you been woken by an attack of shortness of Yes 1 
breath at any time in the last 12 months? No 0 
Cough and phlegm from the chest 
6 Have you been woken by an attack of coughing at Yes 1 
any time in the last 12 months? No 0 
7 Do you usually cough first thing in the morning? Yes 1 
No 0 
8 Do you usually cough during the rest of the day, or Yes 1 
at night? No 0 
If YES, go on to Question 8.1 
If NO, skip to Question 9 
8.1 Do you cough like this on most days/nights for as Yes 1 
 much as three or more months in each of the last No 0 
two years? 
9 Do you usually bring up any phlegm from your chest Yes 1 
first thing in the morning? No 0 
10 Do you usually bring up any phlegm from your chest Yes 1 
during the day, or at night? No 0 




     If NO, skip to Question 11       
              
 10.1 Do you bring up phlegm like this on most days/ Yes 1   
   nights for as much as three or more months in each  No 0   
   of the last two years?             
   Breathing                 
 11 Do you ever have trouble with your breathing? Yes 1  
     If YES, go on to Question 11.1   No 0   
     If NO, skip to Question 12       
              
 11.1 Do you have this trouble:       
     
Give all 
options at 
once             
     Insert a cross (X) next to one answer only     
   a) continuously so that your breathing is never quite right? 1  
   b) repeatedly, but it goes away completely between the      
       times when it troubles you?    2   
   c) only rarely?      3   
              
 12 Are you disabled from walking by a condition other  Yes 1  
   than heart or lung disease?   No 0   
   If YES, state the condition          
   and go on to Question 13         
   If NO, go to Question 12.1         
              
 12.1 Are you troubled by shortness of breath when   Yes 1  
   hurrying on level ground or walking up a slight hill? No 0   
     If YES, go on to Question 12.1.1       
     If NO, skip to Question 13       
              
 12.1.1 Do you get short of breath walking with other  Yes 1  
   people of your own age on level ground? No 0   
              
 12.1.2 Do you have to stop for breath when walking at  Yes 1  
   your own pace on level ground?  No 0   
                       
   Asthma                 
 13 Have you ever had asthma?    Yes 1  
     If YES, go on to Question 13.1   No 0   
     If NO, skip to Question 13.8       
              
 13.1 If yes, was this confirmed by a doctor?  Yes 1  
          No 0   




   asthma?          
     
Give all 
options at 
once              
     Insert a cross (X) next to one answer only     
   a)  Only before you were 17 years old   1  
   b)  Only at the age of 17 years or older   2   
   c)   Both        3   
     
The following references to "attack" of 
asthma      
     refers to episodes of wheezing, shortness of     
     
 breath, chest tightness or cough attributed 
to      
     asthma             




old      
   you had your  first attack of asthma?      
              
 13.3.2 How old were you when you had your most      




old      
              
 13.4 Which months of the year do you usually have     
   attacks of asthma?        
     Answer ALL questions, insert a cross (X)     
              
 13.4.1 January/February    Yes 1  
          No 0   
              
 13.4.2 March/April     Yes 1  
          No 0   
             
 13.4.3 May/June     Yes 1  
          No 0   
              
 13.4.5 September/October    Yes 1  
          No 0   
              
 13.4.6 November/December    Yes 1  
          No 0   
              
              
 13.5 Have you had an attack of asthma in the last  Yes 1  
   12 months?     No 0   
     If YES, go on to Question 13.5.1       
     If NO, skip to Question 13.6         




   the last 12 months?        
     
Give all 
options at 
once              
     Insert a cross (X) next to one answer only     
   a) Every day      1  
   b) More than 2 times a week    2   
   c) More than 1 time per month   3   
   d) 3 to 12 times in the whole year   4   
   e) 1 to 2 times in the whole year   5   
              
 13.6 Are your chest symptoms caused by, or made      
    worse by any of the following:      
     Answer all questions, insert a cross (X)     
 13.6.1 Contact with animals/pets   Yes 1  
          No 0   
              
 13.6.2 Grass or flowers     Yes 1  
          No 0   
              
 13.6.3 Heavy exercise     Yes 1  
          No 0   
              
 13.6.4 Breathing cold air     Yes 1  
          No 0   
              
 13.6.5 Dusts or sprays at work    Yes 1  
          No 0   
              
 13.6.6 Tobacco or other smoke    Yes 1  
          No 0   
              
 13.6.7 Change in the weather    Yes 1  
          No 0   
 13.7 Do your chest symptoms seem better or worse      
   when you are away from work (for example, on      
   weekends, off-shift and annual leave)?      
     
Give all 
options at 
once              
     Insert a cross (X) next to ONE answer only     
   a)  Stay the same      1  
   b)  Get better      2   
   c)  Get worse      3   
              




   or wheezy?     No 0   
     If YES, go on to Question 13.8.1        
     If NO, skip to Question 13.9       
              
 13.8.1 When  did you first notice having problems with      
   chest tightness or wheeze at work? Month   Year    
                       
 13.8.2 Is there anything that you work with (specific Yes 1   
    activities in tobacco farming and related activities)  No 0   
   that causes you to have these chest  symptoms?     
     If YES, go on to Question 13.8.3        
     If NO, skip to Question 13.9       
              
 13.8.3 What do you think is causing these symptoms?      
                       
              
 13.9 Have you ever had to change or leave your work  Yes 1  
   area, either temporarily or permanently, in this company No 0   
   or any other company because of any chest symptoms?      
     If YES, go on to Question 13.9.1        
     If NO, skip to Question 13.10       
              
 13.9.1 What type of job were you doing when this      
   happened?          
                       
              
 13.9.2 Was this job related to tobacco farming? Yes 1  
     If YES, go on to Question 13.9.2.1  No 0   
     If NO, skip to Question 13.10       
              
 13.9.2.1 What area/section did you move to?       
                       
              
 13.9.2.2 What job did you do there?       
                       
              
 13.9.2.3 Did your symptoms improve when you changed Yes 1  
   jobs?       No 0   
              
 13.10. Have you ever worked in a job or jobs that exposed you  Yes 1  
   to other than tobacco farming?   No 0   
     If YES, go on to Question 13.10.1.     
      List the jobs beginning with the most recent     
     If NO, skip to Question 13.11       




 13.10.1 What was or is this job?                
      (if current job write 'current job' and specify)   
              
 13.10.2 Before that?                
              
                       
 13.11 Has there ever been an instance when you inhaled Yes 1   
   a large amount of vapour, gas or fumes in any of  No 0   
   these jobs that resulted in you developing a tight chest,      
   wheeze or cough?         
     If YES, go on to Question 13.11.1.      
     If NO, skip to Question 13.12       
              
 13.11.1 What was or is this job?               
     (if current job write 'current job' and specify)   
              
 13.12 Are you using any medicines, including inhalers/ Yes 1  
   pumps, nebulizers, syrups or tablets, for asthma or  No 0   
   breathing problems?        
     If YES, go on to Question 13.12.1, showing      
     
examples of each. If NO, skip to question 
13.13     
              
 13.12.1 Which medicines?                
                    
                    
              
 13.12.2 Do you take these medicines every day even  Yes 1  
   when you do not have any trouble breathing? No 0   
              
 13.13 Have you ever been treated for any of the      
   following:         
     Answer all questions         
              
 13.13.1 Repeated chest infections as a child  Yes 1  
          No 0   
          
Unknow
n 2   
              
 13.13.2 Tuberculosis (TB)     Yes 1  
          No 0   
          
Unknow
n 2   
              
 13.13.3 Chronic bronchitis    Yes 1  




13.13.4 HIV Status Positive 1 
please verify with health passport Negative 0 
otherwise, offer provider initiated testing 
Unknow
n 2 
Nose and eye symptoms 
14 Have you ever had any nose or eye problems or Yes 1 
allergies such as allergic rhinitis ? No 0 
If YES, go on to Question 14.1 
Answer all questions 
If NO, skip to Question 14.4 




14.2 During the past 12 months have you had two or 
more episodes of: 
14.2.1 Sneezy, itchy or runny nose when you did not Yes 1 
have a cold or flu? No 0 
14.2.2 Red, itchy or watery eyes Yes 1 
No 0 
14.2.3 Do you usually have the nose or eye symptoms Yes 1 
at any particular time of the year? No 0 




Insert a cross (X) next to ONE answer only 
a) Winter 1 
b) Summer 2 
c) Spring 3 
d) Autumn 4 
If YES to any of question 14.2, go on to 
Question 14.3 
If NO, skip to Question 14.4 
14.3 Do your nose or eye symptoms seem better or 
98 
worse  when you are away from work (for example, on 




Insert a cross (X) next to ONE answer only 
a) Stay the same 1 
b) Get better 2 
c) Get worse 3 
14.4 Does being at work ever cause you to have sneezy/ Yes 1 
itchy/runny nose or red/itchy/watery eyes? No 0 
If YES to any one of the above, go on to 
Question 14.4.1 
If NO, skip to Question 14.6 
14.4.1 Since when have you been having these 
symptoms at work? Month Year 
14.4.2 Is there anything that you work with (e.g. "fresh"vs  Yes 1 
"dry" tobacco, dust, pesticides) or any other  No 0 
substance that causes you to have these symptoms? 
If YES, go on to Question 14.4.3 
If NO, skip to Question 14.5 
14.4.3 What do you think is causing these symptoms? 
14.5 Are you using any medicines, including nose  Yes 1 
sprays, drops, tablets or injections, for your nose or eye No 0 
symptoms at present? 
If YES, go on to Question 14.5.1 
If NO, go on to Question 14.6 
Present a chart with different 
allergy medicines 
(N.B. a worker might show you his/her 
medicines). 
14.5.1 Which medicines? 
14.6 Did you have hay fever (itchy or watery eyes/nose) Yes 1 
as a child? No 0 
GREEN TOBACCO SICKNESS SYMPTOMS 
15 Have you ever had any of the following symptoms after coming into 
99 
 contact with tobacco leaves? 
If NO, skip to Question 15.8 
Insert a cross (X) next to all  that apply 
a) Headache 1 
b) Dizziness 2 
c) Nausea 3 
d) Vomiting 4 
15.1 How soon after work did you get the symptoms? 
a) same day 1 
b) day after 2 
c) 2 days after 3 
d) 3 days after 4 
e) a week or more later 5 
15.2 When did you have your most 





15.3 During which farm activities do you usually have 
the symptoms in (15) above 
Answer ALL questions, insert a cross (X) 
15.3.1 Sowing Yes 1 
No 0 
15.3.2 Transplanting Yes 1 
No 0 
15.3.3 Harvesting Yes 1 
No 0 
15.3.4 Curing Yes 1 
No 0 
15.3.5 Other Yes 1 
No 0 
Specify 
15.4 Have you had any of the reported symptoms in (15) in the last Yes 1 
12 months? No 0 
If YES, go on to Question 15.3.1 




 15.4.1 How many episodes of GTS  symptoms have you had in       
   the last 12 months?        
     
Give all 
options at 
once              
     Insert a cross (X) next to one answer only     
   a) None       0  
   b) One       1   
   c) Two       2   
   d) Three       3   
   e) Four or more      4   
              
 15.5 Are your symptoms caused by, or made      
    worse by any of the following:      
     Answer all questions, insert a cross (X)     
              
 15.5.1 harvesting tobacco    Yes 1  
          No 0   
              
 15.5.2 stacking      Yes 1  
          No 0   
              
 15.5.3 dust       Yes 1  
          No 0   
              
 15.5.4 curing tobacco    Yes 1  
          No 0   
              
 15.5.5 pesticde sprays at work    Yes 1  
          No 0   
              
 15.5.6 Tobacco or other smoke    Yes 1  
          No 0   
              
 15.5.7 Change in the weather    Yes 1  
          No 0   
               
 15.6 Do your symptoms seem better or worse      
   when you are away from work (for example, on      
   weekends, off-shift and annual leave)?      
     
Give all 
options at 
once              
     Insert a cross (X) next to ONE answer only     
   a)  Stay the same      1   




   c)  Get worse      3   
              
                       
 15.7.1 Is there anything that you work with (specific  Yes 1   
    activities in tobacco production facilities) that   No 0   
   causes you to have these symptoms?      
     If YES, go on to Question 13.8.3        
     If NO, skip to Question 13.9       
              
 15.7.2 What do you think is causing these symptoms?      
                       
                       
              
 15.8 Have you ever had to change or leave your work  Yes 1  
   area, either temporarily or permanently, in this  No 0   
   company or any other company because of any      
    chest symptoms?              
     If YES, go on to Question 13.9.1        
     If NO, skip to Question 13.10       
              
 15.9.1 What type of job were you doing when this      
   happened?          
                       
              
 15.9.2 Was this job in this company?   Yes 1  
     If YES, go on to Question 13.9.2.1  No 0   
     If NO, skip to Question 13.10       
              
 15.9.2.1 What area/section did you move to?       
                       
              
 15.9.2.2 What job did you do there?       
                       
              
 15.9.2.3 Did your symptoms improve when you changed Yes 1  
   jobs?       No 0   
             
 C. ALCOHOL AND DRUG USE               
 16.1 Do you drink alcohol or did you drink before? Yes 1  
  If no, proceed to 16.2    No 0   
  
 
          
 16.1.1 Have you ever felt that you should drink less alcohol? Yes 1  
  
 
      No 0   
  
 





Have people ever angered you by criticizing your drinking 
habits? Yes 1  
  
 
      No 0   
  
 
          
 16.1.3 Have you ever felt guilty or bad because you drink alcohol? Yes 1  
  
 
      No 0   
  
 
          
 16.1.4 Have you ever had a drink early in the morning  Yes 1  
  to make you feel better?    No 0   
             
 16.2 Have you ever smoked tobacco (cigarettes or pipe) for  Yes 1  
  as long as a year?     No 0   
  (‘Yes’ means at least 20 packs of cigarettes or 30 grams of      
  tobacco in a lifetime or at least one cigarette per day for      
  one year)          
  If no go to section D        
 16.2.1 
How old were you when you started smoking? Age in Years    
  
 
          
 16.2.2 Do you smoke currently? Yes 1  
  (‘Yes’ means smoking tobacco in the last month  No 0   
  or more)          
 16.2.3 If no, how old were you when you stopped smoking?    
  
 
      
Age in 
years    
 16.2.3 How much do/did you now smoke on average?     
 16.2.3.1 Number of cigarettes per day     
 16.2.3.2 Pipe tobacco in grams/week       
  
 
          
 16.2.4 Do you or did you inhale the smoke?  Yes 1  
  
 
      No 0   
  
 
          
 16.3 Have you been regularly exposed to tobacco smoke  Yes 1  
  from other people smoking cigarettes or pipe in the  No 0   
  last 12 months?         
   (‘Regularly’ means on most days or nights)     
 16.4 Do you take drugs or have taken drugs before?              Yes 1  
  
 
      No 0   
  
 
          
  If YES, please state for how many years     
             
             
 D. FARM ACTIVITIES INVOLVED             
             




              
 2 Job Title                   
   Get a short description of the job     
                       
                       
                       
                       
              
 3 Permanent/casual/tenant:          
              
 4 How long have you worked in this job?         Years     
          Months     
             
 5 What types of tobacco do you work with?       
     please tick all that apply       
   a)  Burley       1   
   b) Flue cured      2   
   c) Northern Division Dark fired (NDDF)   3   
   d) Southern Division Fired (SDF)   4   
   g) Other       5   
   Specify:                   
              
              
 6 Do you ever do other farm tasks during your shift on   Yes 1   
   a regular basis (almost every day)?  No 0   
   If Yes, which jobs?                
                   
              
             
             
 7 Does your job involve these activities?   Yes 1   
     
tick all that 
apply          No 0   
     
If YES, continue with 3.5.1 (one or more), If 
NO go to 3.5.2     
   a) Tilling     1   
  b) Spraying   2   
  c) Harvesting   3   
  d) Stacking    4   
  e) Curing    5   
  f) Sorting    6   
  g) Planting/transplanting   7   
  h) Sowing   8   
  i) Weeding   9   




  m) Administration   11   
   n) General cleaning  12   
   o) Cleaning equipment  13   
   p) Cleaning Personal Protective Equipment  14   
   q) Other       15   
   Specify:                   
              
 7.1 How much dust would you say your current job produces:     
     
Give all options at 
once            
     Insert a cross (X) next to ONE answer only     
   a) No dust      0  
   b) A little        1   
   c) A medium amount     2   
   d) A lot        3   
              
 7.1.1 How far do you work from the source of the dust?     
     
Give all 
options at 
once              
     Insert a cross (X) next to ONE answer only     
   a) Right next to the source    1  
   b) About 1-2 metres away    2   
   c) More than 3 metres away    3   
   d) Does not apply      4   
              
   EXPOSURE TO PESTICIDES AT WORK       
 7.2 
Does your work 
involve application             Yes 1  
   
(spray/mix) of 
pesticides             No 0   
                    
 7.2.1 
If YES which 
pesticides do you 
use                                               
   
                   
   
                   
   
                   
   
                 
 7.2.2 
When last did you 
apply          Month   Year     
   pesticides?                 
   
                 
 7.2.3 
How many months 
a year do you                  
   apply pesticides?                 
   





How many days 
per month do you                  
   
apply pesticides in 
the spraying 
months?                 
   
                 
 7.2.5 
Total number of 
days per year                  
   
                 
 7.2.6 
How many hours 
per day do you                   
   
work with 
pesticides?                 
   
                 
 7.2.7 
Do you do other 
field work while 
others               Yes 1   
   spray pesticide?             No 0   
                    
 7.2.7.1 
If yes, how many 
times per year?                  
                     
   
ENVIRONMENTAL 
PESTICIDES 
EXPPOSURE                  
 7.3 
Do you come into 
come into contact 
with pesticides              Yes 1   
   
outside the house 
while spraying 
occurs?              No 0   
                     
 7.3.1. 
Does the pesticide 
spraying come into 
the house?              Yes 1   
                No 0   
                    
 7.3.2 
Do you go into in 
the fields soon 
after             Yes 1   
   
 spraying or come 
into contact with              No 0   
   sprayed surfaces?                  
                     
   
HOME PESTICIDES 
EXPOSURE                  
 7.4 
Do you use 




   
(spray/mix) of 
pesticides             No 0   
                    
 7.4.1 
If YES which 
pesticides do you 
use                                               
   
                   
   
                   
   
                   
   
                 
 7.4.2 
When last did you 
use home 
pesticides?         Month   Year     
   
                 
   
EXPOSURE TO 
BIOMASS FUEL                 
 8.1 
Are you exposed to 
smoke from open 
fires           Yes 1   
   
used for cooking, 
heating, or curing 
purposes?          No 0   
                 
 8.1.1. 
What is the 
source of this 
particular smoke? 
(tick all that 
apply)              
                 
   firewood           1  
   charcoal           2   
   coal           3   
   
other (please 
specify)             4   
                 
 8.1.2 
If YES where do 
you come into 
contact                         home 1  
   
 with 
environmental 
smoke?          work 2   
   
              
 8.1.3 
What tasks expose 
you to smoke?              
   Tick all that apply              
   
 cooking       1  
   





When last did 











How many days 






Total number of 
days per year 
8.1.8 
How many hours 




Use of Personal Protective Equipment 
9.1 Do you use any personal protective equipment on a  Yes 1 
regular basis (almost every day) while doing your job? No 0 
If NO, skip to Question 9.4 
9.1.1 During which of the following do you were PPE? (Tick all that apply) 
a) Tilling 1 
b) Spraying 2 
c) Harvesting 3 
d) Stacking 4 
e) Curing 5 
f) Sorting 6 
108 
g) Planting/transplanting 7 
h) Sowing 8 
i) Weeding 9 
l) Transport 10 
m) Administration 11 
n) General cleaning 12 
o) Cleaning equipment 13 
p) Cleaning Personal Protective Equipment 14 
q) Other 15 
Specify:
9.2.1 Which of the following personal protective  
equipment do you use on a regular basis  (almost every 
day while working)?  
9.2.1.1 Goggles: Yes 1 
No 0 
9.2.1.2 Gloves: Yes 1 
No 0 
9.2.1.3 Mask: Yes 1 
No 0 
9.2.1.4 Work suite Yes 1 
No 0 
9.2.1.5 Other: Yes 1 
No 0 
Specify: 
If NO to all of the previous questions, skip to 
Question 9.4 
9.2.2 How long have you been wearing the personal protective 
equipment on a regular basis (almost every day) while working? 







9.3 Is PPE provided free of charge? Yes 1 
No 0 
9.4 Do you have wash rooms to Yes 1 
bath after applications No 0 
Do you have hand washing facilities at work Yes 1 
to wash hands after work? No 0 
Previous jobs in present company 
10 Before doing this job at this company, did you do a Yes 1 
 different job here? No 0 
If NO, skip to question 11 
If YES, continue with question 10.1 
10.1 What other jobs did you do here? 
Start with the first job and work forward, 
getting a one-line 
description of each job. If casual worker, 
denote each period of 
employment as a separate job. For 
continuous years of seasonal  
work consider as one job (provided no 
broken years’ service) 
Job 1 
10.1.1 Area/section 
10.1.2 Job Title 
Get a short description of the job 
10.1.3 Permanent/casual/tenant:  





              
 10.1.5 In which area were you working?      
   a) Tilling    1   
   b) Spraying    2   
   c) Harvesting    3   
   d) Stacking     4   
   e) Curing    5   
   f) Sorting    6   
   g) Planting/transplanting    7   
   h) Sowing     8   
   i) Weeding     9   
   j) Cleaning     10   
   l) Transport      11   
   m) Administration     12   
   n) Other     13   
   Specify:               
              
 10.1.7 How much dust would you say your previous job produced:    
     
Give all options at 
once            
     Insert a cross (X) next to ONE answer only     
   a) No dust     0   
   b) A little      1   
   c) A medium amount     2   
   d) A lot      3   
             
 10.1.8 Did your job involve handling pesticides? Yes 1   
     
Give all options at 
once        No 0   
     
If YES, continue with 4.1.8 (one or more), If 
NO go to 4.1.9     
              
 10.1.7. How much contact with pesticides did you have in your previous job?    
     
Give all options at 
once            
     Insert a cross (X) next to ONE answer only     
   a) None     0   
   b) A little        1   
   c) A medium amount     2   
   d) A lot      3   
               
 10.1.7 How much contact with tobacco leaves did you have in your previous job?   
     
Give all options at 
once            
     Insert a cross (X) next to ONE answer only     
   a) None     0   




   c) A medium amount     2   
   d) A lot      3   
               
 10.1.7 How much contact with smoke did you have in your previous job?    
     
Give all options at 
once            
     Insert a cross (X) next to ONE answer only     
   a) None       0   
   b) A little        1   
   c) A medium amount     2   
   d) A lot        3   
              
 10.1.10 Did you use any personal protective equipment  Yes 1   
   on a regular basis (almost every day) while doing your  No 0   
   job?           
     If NO, skip to Question 4.2.1       
     If YES, continue with Question 4.1.10     
              
 
10.1.10.1-
5 Which of the following personal protective      
   equipment did you use on a regular basis  (almost every      
   day)?           
              
 
10.1.10.
1 Goggles:           
              
 
10.1.10.
2 Gloves:           
              
 
10.1.10.
3 Mask:           
              
 
10.1.10.
4 Aprons:           
              
 
10.1.10.
5 Other:           
   If NO to all of the previous questions, skip to Question 4.2.1      
   If YES to any one of the above questions, continue with      
   Question 4.1.11             
              
 10.1.11 How long have you been wearing the personal protective      
   equipment on a regular basis (almost every day) while working?    
   (0= 0 , 1=up to 1 year, 2= 2-3 years, 3= >3 years)     
 
10.1.11.
1 Goggles          






2 Gloves:          
              
 
10.1.11.
3 Mask:          
              
 
10.1.11.
4 Aprons:           
              
 
10.1.11.
5 Other:           
                       
   Job 2                   
              
 10.2.1 Area/section              
              
 10.2.2 Job Title                   
     Get a short description of the job     
                       
                       
                       
                       
              
 10.2.3 Permanent/casual/tenant:          
              
 10.2.4 How long did you work in this job?         Years     
          Months     
              
 10.2.5 In which area were you working?      
   a)   Tilling        
   b)   Spraying         
   c)    Harvesting        
   d)   Stacking         
   e)  Curing        
   f)   Sorting        
   g)   Planting/transplanting        
   h)   Sowing       
   i)   Weeding        
   j)   Cleaning        
   l)    Transport        
   m)  Administration        
   n)  Other        
   Specify:                   
              




     
Give all options at 
once            
     Insert a cross (X) next to ONE answer only     
   a) No dust      0   
   b) A little        1   
   c) A medium amount     2   
   d) A lot        3   
             
 10.2.8 Did your job involve handling pesticides? Yes 1   
     
Give all options at 
once        No 0   
     
If YES, continue with 4.1.8 (one or more), If 
NO go to 4.1.9     
              
 10.2.7 How much contact with pesticides did you have in your previous job?    
     
Give all options at 
once            
     Insert a cross (X) next to ONE answer only     
   a) None     0   
   b) A little      1   
   c) A medium amount     2   
   d) A lot      3   
               
 10.2.7 How much contact with tobacco leaves did you have in your previous job?   
     
Give all options at 
once            
     Insert a cross (X) next to ONE answer only     
   a) None     0   
   b) A little      1   
   c) A medium amount     2   
   d) A lot     3   
               
 10.2.7 How much contact with smoke did you have in your previous job?    
     Give all options at once      
     Insert a cross (X) next to ONE answer only     
   a) None     0   
   b) A little      1   
   c) A medium amount     2   
   d) A lot      3   
              
 10.2.10 Did you use any personal protective equipment  Yes 1   
   on a regular basis (almost every day) while doing your  No 0   
   job?     
   If NO, skip to Question 4.2.1     
   If YES, continue with Question 4.1.10     






5 Which of the following personal protective      
   equipment did you use on a regular basis  (almost every      
   day)?           
              
 
10.2.10.
1.  Goggles:          
              
 
10.2.10.
2 Gloves:         
              
 
10.2.10.
3 Mask:          
              
 
10.2.10.
4 Aprons:        
              
 
10.2.10.
5 Other:          
   If NO to all of the previous questions, skip to Question 4.2.1      
   If YES to any one of the above questions, continue with      
   Question 4.1.11     
              
 10.2.11 How long have you been wearing the personal protective      
   equipment on a regular basis (almost every day) while working?    
   (0= 0 , 1=up to 1 year, 2= 2-3 years, 3= >3 years)     
 
10.2.11.
1 Goggles        
              
 
10.2.11.
2 Gloves:         
              
 
10.2.11.
3 Mask:         
              
 
10.2.11.
4 Aprons:         
              
 
10.2.11.
5 Other:         
              
                       
   Previous work experience           
              
 11 Name all the previous workplaces that you have      
   worked in, when not working in this company or before      
   coming to work in this company:      




   (including all other companies and jobs done)     
              




















   
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                       
             
  THANK YOU FOR ANSWERING THE QUESTIONNAIRE     
             
             
  Interviewer's name:               
             
   Date of interview: Day   Month   Year     







APPENDIX 5: LFT PRETEST QUESTIONNAIRE       
 
 
UCT STUDY OF OBSTRUCTIVE LUNG DISEASES AMONG              
        TOBACCO FARMERS IN MALAWI – 2017/2018    
 
 





       
      
Survey Number  ________________________   
      
       
       
6. Date of interview:      
  Day____Month_________Year______    
       
       
B.HEALTH PROBLEMS      
Recent chest infections       
1. Have you had the flu, sinusitis or a chest infection in the past 3 weeks?  
   Yes                  (1)   
   No                   (2)   
       
2. Are you being treated for Tuberculosis (TB)?    
   Yes                  (1)   
   No                   (2)   
       
2.1 If yes, for how long?  ________months         ________weeks   
       
If YES, to question no 2, indicate to person that the tests will not be    
done today. Schedule another appointment in three months      
since the start of TB medication. If the person has already had three    
months of treatment, proceed with the rest of the screening questions   
and the post-bronchodilator test.       
       
       
9. Have you had asthma in the past?     
   Yes                  (1)   
   No                   (2)   
       
9.1 Do you have asthma now?      
   Yes                  (1)   
   No                   (2)   





. Have you had any 
of the following 
symptoms in the 
past 12 months?  
  
 
    
    (at night, with exercise, exposure to cold air, viral infections, work exposures) 
a)      chest tightness        
b)      shortness of breath      
c)      wheezing or whistling in your chest      
d)      dry cough       
       
12. Do you currently have any of these symptoms?     
   Yes                  (1)   
   No                   (2)   
       
12.1   If Yes, which ones?      
a)      chest tightness        
b)      shortness of breath      
c)      wheezing or whistling in your chest      
d)      dry cough       
       
       
3. Have you had a heart attack or stroke in the last month?      
   Yes                  (1)   
   No                   (2)   
       
4. Do you have epilepsy?       
   Yes                  (1)   
   No                   (2)   
       
5. Have you had an operation in the last 12 months?        
   Yes                  (1)   
   No                   (2)   
       
       
If YES to any of the above Q3-5, indicate to the person that the    
lung function tests will not be done.  If NO, proceed with the rest    
of the screening questions         
       
6.For women:       
       
6.1 Are you Pregnant?      Yes                  (1)   
   No                   (2)   
       
6.2 Are you Breastfeeding?   Yes                  (1)   
   No                   (2)   
       
If Pregnant, indicate to the person that the Lung Function Test will    
not be done today           
      
If Breastfeeding, proceed with Lung Function Test with Post-     




       
       
C. MEDICATION USAGE (show booklet)     
1. Are you taking any medicine/s from a doctor or clinic at the    
moment for asthma, and or hayfever?     
  Yes                  (1)    
  No                   (2)    
       
1.1 If yes, what are you taking and when last did you take them?   
Names                     No. of hours since last dose 
_______________________________ ____________    
______________________ ________________ ____________    
______________________ ________________ _____________    
       
2. Are you taking any medicine/s from a doctor or clinic at the   
 moment for any heart condition, or your eyes?     
  Yes                  (1)    
  No                   (2)    
       
If short-acting beta-2-agonist or anti-cholinergic inhalers used in    
the last 4 hours or long-acting MDI or theophylline used in last 8    
hours, reschedule spirometry and counsel accordingly.     
       
       
D. RECENT FOOD INTAKE      
1. Did you drink coffee, tea or coca-cola in the last 6 hours?    
  Yes                  (1)    
  No                   (2)    
       
2. Did you have anything to eat or drink in the last hour?    
  Yes                  (1)    
  No                   (2)    
       
3. Have you smoked in the last hour?     
  Yes                  (1)    
  No                   (2)    
       
If YES to Question 2 or 3, reschedule  test for at least 1 hour   
 later the same day or another date.        
APPENDIX 6: LFT DATA SHEET 
UCT STUDY OF OBSTRUCTIVE LUNG DISEASES AMONG TOBACCO 
FARMERS IN MALAWI – 2017 
 LUNG FUNCTION TESTS DATA COLLECTION SHEET 
                                                                                             
 
                                                                                          CARD 1 
     Record Number     1-3 




     Date        10-15 
           DAY      MONTH      YEAR       
 
                     
1. Participant’s blood pressure      systolic 
           
      diastolic 
 
      YEARS     
2. Participant's age    16-17 
         MALE  FEMALE 
3. Participant's gender    18 
 
     CENTIMETRES 
4.1 Participant's height  .   19-21 
         KILOGRAMS 
4.2 Participant's weight     22-24 
 




6. PREDICTED FEV1     31-33 
 
7. INITIAL FEV1 and FVC                     FEV1                    FVC                  
    (up to 8 attempts)       1                                     34-39 
       2                                     40-45 
       3                                     46-51 
       4                                     52-57 
       5                                     58-63 
   
         7.1 Number of rejected attempts                64 
 
8. Best INITIAL FEV1 as % of predicted FEV1         65-67 
    (divide best results from No. 7 by results from No. 6) 
 
BRONCHODILATOR CHALLENGE ONLY 
 
9. FEV1 and FVC  
                                                                       FEV1                 FVC 
         9.1 Record Best two technically satisfactory                           68-73 
         Manoeuvres (up to 8 attempts)                                         74-79 
 
         9.2 Number of rejected attempts                80 
                     
       CARD 2 
10. Best POST-BRONCHODILATOR FEV1 as % of initial FEV1    1-3 
 (divide best results from No. 9 by best results from No. 7) 












12. Technologist initial’s ______________  4              13 
 
13. Room temperature: ______________   5-6              13 
      (degrees celcius) 
     NO YES 
14 Lung function record appended    7 
 
 
 
